syndrome	score	normalized_score
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	1.0204082	100.0
TERMINAL OSSEOUS DYSPLASIA; TOD	1.00280112	98.27450622211776
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	1.0027933	98.27373986214536
#131960 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBS-MP;;SPECKLED HYPERPIGMENTATION WITH PUNCTATE PALMOPLANTAR KERATOSES ANDCHILDHOOD BLISTERING	1.0	97.99999647200012
NEUROFIBROMATOSIS, TYPE I	0.61426634	60.19809915286842
Dyschromatosis universalis hereditaria 3	0.5526316	54.15789485031578
TUBEROUS SCLEROSIS	0.521252795	51.0827720710202
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.504061855	49.398060011669834
SECKEL SYNDROME 2; SCKL2	0.5024891	49.24393002721852
#615327 DOWLING-DEGOS DISEASE 2; DDD2	0.5	48.99999823600006
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.5	48.99999823600006
NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL	0.5	48.99999823600006
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.3550721	34.79706454730567
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.3358221	32.91056461521967
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.33454659	32.78556463971967
DYSCHROMATOSIS SYMMETRICA HEREDITARIA 1	0.333333	32.66663282400121
%615674 DOWLING-DEGOS DISEASE 3; DDD3	0.333333	32.66663282400121
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.333333	32.66663282400121
#613707 LEOPARD SYNDROME 3; LPRD3	0.22428018499999997	21.97945733873953
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.21257898	20.832739290021387
HURLER SYNDROME	0.204851485	20.075444807283986
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.204851485	20.075444807283986
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.2	19.599999294400025
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.2	19.599999294400025
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.2	19.599999294400025
LEPTIN DEFICIENCY OR DYSFUNCTION	0.2	19.599999294400025
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.2	19.599999294400025
#615513 IMMUNODEFICIENCY 14; IMD14;;ACTIVATED PI3K-DELTA SYNDROME; APDS;;P110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY,AND IMMUNODEFICIENCY; PASLI	0.2	19.599999294400025
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.2	19.599999294400025
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.16216436999999997	15.892107687884119
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.13638753499999998	13.365977948824789
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.13553390999999998	13.28232270183638
#611554 LEOPARD SYNDROME 2	0.13273279	13.00781295171873
HYPERPIGMENTATION, FAMILIAL PROGRESSIVE	0.13151919999999998	12.888881136000274
GASTROCUTANEOUS SYNDROME	0.13151919999999998	12.888881136000274
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.12511983499999998	12.261743388577235
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.124294265	12.180837531489848
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.11596248499999999	11.364323120884366
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.11426634	11.198100916868366
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.11238650999999998	11.013877583500404
WATSON SYNDROME	0.11232458999999999	11.007809423718859
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.11111099999999999	10.888877608000405
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.11111099999999999	10.888877608000405
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.11111099999999999	10.888877608000405
114030 CAFE-AU-LAIT SPOTS, MULTIPLE	0.11111099999999999	10.888877608000405
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.102642385	10.058953367877677
Mulchandani-Bhoj-Conlin syndrome	0.08285557	8.119845567685559
CHROMOSOME 1P36 DELETION SYNDROME	0.07735107499999999	7.580405077105416
HYPER-IGD SYNDROME	0.0743707	7.288328337620179
CRI-DU-CHAT SYNDROME	0.07352185500000001	7.205141530614906
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.07346775500000001	7.1998397308057696
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.0730398	7.157900142315595
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0730398	7.157900142315595
MOWAT-WILSON SYNDROME; MOWS	0.07195692	7.051777906135995
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.07154483500000001	7.011393577589832
CHROMOSOME 16p13.3 DELETION SYNDROME	0.070728555	6.931398140469666
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.070312415	6.890616421937809
BARDET-BIEDL SYNDROME 1; BBS1	0.070304595	6.889850061965397
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.06946782	6.807846114917539
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.068724885	6.735038487538613
#608980 BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	0.0666667	6.533336364799889
BARDET-BIEDL SYNDROME 11; BBS11	0.0666667	6.533336364799889
BARDET-BIEDL SYNDROME 12; BBS12	0.0666667	6.533336364799889
NIPPLES, SUPERNUMERARY	0.0666667	6.533336364799889
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.06407772	6.279616333933811
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.05670041	5.55663997996096
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.05664779	5.551483220146604
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.05537228	5.426483244646603
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.054584785	5.349308737424884
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.05384519	5.276828430034176
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.05384519	5.276828430034176
HAIRY PALMS AND SOLES	0.0526316	5.157896614315721
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3	0.0526316	5.157896614315721
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.0526316	5.157896614315721
DARIER-WHITE DISEASE; DAR	0.0526316	5.157896614315721
MASTOCYTOSIS, CUTANEOUS; MASTC	0.0526316	5.157896614315721
PSEUDOXANTHOMA ELASTICUM; PXE	0.0526316	5.157896614315721
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.0526316	5.157896614315721
LENTIGINOSIS, INHERITED PATTERNED	0.0526316	5.157896614315721
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.0526316	5.157896614315721
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0526316	5.157896614315721
PEUTZ-JEGHERS SYNDROME	0.0526316	5.157896614315721
PHEOCHROMOCYTOMA	0.0516582	5.062503417749877
OROFACIODIGITAL SYNDROME XIV; OFD14	0.05069915	4.968516521133404
Myhre syndrome	0.048928115	4.794955097381616
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.04783611	4.68793861123421
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.04723197	4.6287328933656156
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.045956460000000005	4.503732917865615
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.045594420000000004	4.468252999142892
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.04529022	4.438441400216108
NEUROFIBROMATOSIS, TYPE II	0.0449406	4.404178641449568
HOLOPROSENCEPHALY 3; HPE3	0.044921224999999995	4.4022798915179235
MEHMO SYNDROME; MEHMO	0.044921224999999995	4.4022798915179235
HOLOPROSENCEPHALY 11	0.04407663	4.319509584497654
JOUBERT SYNDROME 26	0.04401471	4.313441424716108
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0439082	4.303003445091876
CHROMOSOME 15Q14 DELETION SYNDROME	0.043645714999999995	4.277279916017922
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.04280112	4.194509608997653
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.04280112	4.194509608997653
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.04280112	4.194509608997653
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.04280112	4.194509608997653
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.04280112	4.194509608997653
LEGIUS SYNDROME	0.041684799999999994	4.08511025293603
HEART AND BRAIN MALFORMATION SYNDROME	0.04127551	4.044999834380006
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.04	3.919999858880005
OROFACIAL CLEFT 11; OFC11	0.04	3.919999858880005
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.037024844999999994	3.6284346793763507
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.036054905	3.5333805627982997
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.035967864999999995	3.524850643105376
WITTEVEEN-KOLK SYNDROME	0.035099464999999996	3.439747446169091
N SYNDROME	0.034887894999999995	3.41901358691551
BRANCHIOOCULOFACIAL SYNDROME	0.034769049999999996	3.407366777334795
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.034397300000000006	3.3709352786463302
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.0340433	3.3362432798952417
FONTAINE PROGEROID SYNDROME; FPS	0.03358147	3.290983941524578
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.033308185	3.264202012488727
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.03319175	3.25279138289951
NIJMEGEN BREAKAGE SYNDROME	0.033165534999999996	3.250222312991996
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.03252551	3.187499865250005
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.03252551	3.187499865250005
BARAITSER-WINTER SYNDROME 1; BRWS1	0.032484315	3.18346275539534
CIRCUMVALLATE PLACENTA SYNDROME	0.032266	3.162067886165556
KABUKI SYNDROME 1	0.031278065	3.0652502596509907
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.031270725	3.0645309396768856
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.03125	3.0624998897500038
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.03125	3.0624998897500038
THYMOMA, FAMILIAL	0.03125	3.0624998897500038
CHOROIDAL OSTEOMA, BILATERAL	0.03125	3.0624998897500038
ANDROGEN INSENSITIVITY SYNDROME	0.03125	3.0624998897500038
ADAMANTINOMA OF LONG BONES	0.03125	3.0624998897500038
#600630 UV-SENSITIVE SYNDROME 1; UVSS1	0.03125	3.0624998897500038
#603956 CERVICAL CANCER	0.03125	3.0624998897500038
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.03125	3.0624998897500038
PAGET DISEASE, EXTRAMAMMARY	0.03125	3.0624998897500038
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.03125	3.0624998897500038
HURIEZ SYNDROME; HRZ	0.03125	3.0624998897500038
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.03125	3.0624998897500038
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.03125	3.0624998897500038
ICHTHYOSIS, X-LINKED	0.03125	3.0624998897500038
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.03125	3.0624998897500038
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.03125	3.0624998897500038
BROOKE-SPIEGLER SYNDROME; BSS	0.03125	3.0624998897500038
#601518 PROSTATE CANCER, HEREDITARY, 1; HPC1;;PRCA1	0.03125	3.0624998897500038
NASOPHARYNGEAL CARCINOMA	0.03125	3.0624998897500038
ONCOCYTOMA	0.03125	3.0624998897500038
#172800 PIEBALD TRAIT; PBT;;PIEBALDISM	0.03125	3.0624998897500038
117600 CEREBRAL SARCOMA	0.03125	3.0624998897500038
CHROMOSOME 10Q26 DELETION SYNDROME	0.031232815	3.0608157598106325
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.030685465	3.007175461741683
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.02984087	2.924405154721414
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.028743715	2.816883968592177
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.02850857	2.7938397594217688
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.027875314999999998	2.7317807716558917
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.02769556	2.7141647822900676
CORNELIA DE LANGE SYNDROME 1	0.027411415	2.686318573292531
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02723306	2.6688397839217672
NAIL-PATELLA SYNDROME	0.02723306	2.6688397839217672
OCULOSKELETODENTAL SYNDROME; OCSKD	0.027225239999999998	2.668073423949356
RECOMBINANT CHROMOSOME 8 SYNDROME	0.026856244999999997	2.6319119152511705
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.026535195	2.6004490163838354
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.026535195	2.6004490163838354
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.026535195	2.6004490163838354
FANCONI ANEMIA	0.026535195	2.6004490163838354
CHIARI MALFORMATION TYPE I	0.026474150000000002	2.594466606599202
CAMURATI-ENGELMANN DISEASE	0.026474150000000002	2.594466606599202
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.02616995	2.5646550076724197
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.02601947	2.549907968203313
KAPUR-TORIELLO SYNDROME	0.02601947	2.549907968203313
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.02601947	2.549907968203313
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.025987845	2.5468087183148858
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.025745990000000003	2.5231069291681507
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0256906	2.5176787093635666
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.0256906	2.5176787093635666
BARATELA-SCOTT SYNDROME	0.02535323	2.4846164505538075
ROBERTS SYNDROME; RBS	0.025329425	2.4822835606377915
CRANIOFRONTONASAL SYNDROME; CFNS	0.02529131	2.4785482907722614
NOONAN SYNDROME 7; NS7	0.025276535	2.4771003408243875
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.024922315	2.4423867820740757
KBG SYNDROME	0.024610295	2.411808823174882
PARIETAL FORAMINA	0.02454022	2.404941473422107
SCLEROSTEOSIS 1; SOST1	0.024532400000000003	2.404175113449696
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.024532400000000003	2.404175113449696
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.024532400000000003	2.404175113449696
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.024201945	2.371790524615541
RITSCHER-SCHINZEL SYNDROME 1	0.02407772	2.359616475053807
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.024069899999999998	2.3588501150813954
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.024046095	2.35651722516538
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.023859205	2.3382020058247277
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.0237657	2.3290385161546134
JOHANSON-BLIZZARD SYNDROME; JBS	0.023741895	2.326705626238597
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.023396705	2.2928770074564278
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.023396705	2.2928770074564278
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.023334785	2.286808847674881
MICROPHTHALMIA, SYNDROMIC 4	0.023253515000000002	2.2788443879616023
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.02321835	2.275398218085664
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.02321835	2.275398218085664
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.02320932	2.2745132781175217
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.023194544999999997	2.2730653281696473
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0228973	2.2439353192183282
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0228973	2.2439353192183282
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.0228973	2.2439353192183282
BRUNNER SYNDROME; BRNRS	0.022583695	2.2132020303247266
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.022583695	2.2132020303247266
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.02255211	2.2101067004361585
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.02255211	2.2101067004361585
SPONDYLOOCULAR SYNDROME; SOS	0.02249019	2.2040385406546124
FLOATING-HARBOR SYNDROME	0.02249019	2.2040385406546124
Retinitis pigmentosa with or without skeletal anomalies	0.022466385	2.2017056507385964
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.022408920000000002	2.196074080941333
MEGAEPIPHYSEAL DWARFISM	0.022408920000000002	2.196074080941333
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0224011	2.195307720968922
SCARF SYNDROME	0.022121195	2.1678770319564267
DEAFNESS AND MYOPIA; DFNMYP	0.022121195	2.1678770319564267
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.022121195	2.1678770319564267
EPISODIC ATAXIA, TYPE 1; EA1	0.0217391	2.130431723304458
SNEDDON SYNDROME	0.0217391	2.130431723304458
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0217391	2.130431723304458
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.0217391	2.130431723304458
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.0217391	2.130431723304458
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.0217391	2.130431723304458
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.0217391	2.130431723304458
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.0217391	2.130431723304458
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0217391	2.130431723304458
EPISODIC ATAXIA, TYPE 3	0.0217391	2.130431723304458
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0217391	2.130431723304458
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.0217391	2.130431723304458
Polyarteritis nodosa, childhood-onset	0.0217391	2.130431723304458
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.0217391	2.130431723304458
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.0217391	2.130431723304458
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.0217391	2.130431723304458
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.0217391	2.130431723304458
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0217391	2.130431723304458
#615399 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2	0.0217391	2.130431723304458
PAPILLOMA OF CHOROID PLEXUS	0.0217391	2.130431723304458
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.0217391	2.130431723304458
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.0217391	2.130431723304458
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.0217391	2.130431723304458
GLUTAMATE MONOSODIUM SENSITIVITY	0.0217391	2.130431723304458
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.0217391	2.130431723304458
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.0217391	2.130431723304458
#613882 HYPOMAGNESEMIA 6, RENAL; HOMG6	0.0217391	2.130431723304458
CRANIOSYNOSTOSIS 2	0.0217391	2.130431723304458
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.0217391	2.130431723304458
MARSILI SYNDROME; MARSIS	0.0217391	2.130431723304458
BLOOM SYNDROME	0.02168371	2.1250035034998733
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.02168371	2.1250035034998733
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.02162179	2.118935343718327
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.02162179	2.118935343718327
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.02162179	2.118935343718327
NOONAN SYNDROME 6; NS6	0.02162179	2.118935343718327
#614809 CFHR5 DEFICIENCY	0.0212766	2.085106724936158
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0212766	2.085106724936158
%613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.0212766	2.085106724936158
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.0212766	2.085106724936158
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.0212766	2.085106724936158
#612923 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3;;AHUS, SUSCEPTIBILITY TO, 3	0.0212766	2.085106724936158
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.0212766	2.085106724936158
HYPEROXALURIA, PRIMARY, TYPE II; HP2	0.0212766	2.085106724936158
CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY	0.0212766	2.085106724936158
COMPLEMENT FACTOR H DEFICIENCY	0.0212766	2.085106724936158
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.0212766	2.085106724936158
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.0212766	2.085106724936158
NEPHROTIC SYNDROME, TYPE 12	0.0212766	2.085106724936158
#612925 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5;;AHUS, SUSCEPTIBILITY TO, 5	0.0212766	2.085106724936158
FECHTNER SYNDROME	0.0212766	2.085106724936158
HEMOGLOBIN--BETA LOCUS	0.0212766	2.085106724936158
ALAGILLE SYNDROME 2	0.0212766	2.085106724936158
#612924 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4	0.0212766	2.085106724936158
#612922 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2;;AHUS, SUSCEPTIBILITY TO, 2	0.0212766	2.085106724936158
#614034 HEME OXYGENASE 1 DEFICIENCY; HMOX1D	0.0212766	2.085106724936158
NEPHROTIC SYNDROME, TYPE 16; NPHS16	0.0212766	2.085106724936158
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0212766	2.085106724936158
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0212766	2.085106724936158
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.0212766	2.085106724936158
#141200 HEMATURIA, BENIGN FAMILIAL; BFH;;THIN-BASEMENT-MEMBRANE NEPHROPATHY;;THIN MEMBRANE NEPHROPATHY; TMN	0.0212766	2.085106724936158
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0212766	2.085106724936158
SICKLE CELL ANEMIA	0.0212766	2.085106724936158
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.0212766	2.085106724936158
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.0212766	2.085106724936158
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.0212766	2.085106724936158
#614131 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 6	0.0212766	2.085106724936158
IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.0212766	2.085106724936158
AMYLOIDOSIS, FAMILIAL VISCERAL	0.0212766	2.085106724936158
109820 BLADDER DIVERTICULUM	0.0212766	2.085106724936158
#612926 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6;;AHUS, SUSCEPTIBILITY TO, 6	0.0212766	2.085106724936158
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0212766	2.085106724936158
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.0212766	2.085106724936158
PTERYGIUM COLLI, ISOLATED	0.0212766	2.085106724936158
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.0212766	2.085106724936158
OROTIC ACIDURIA	0.0212766	2.085106724936158
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.0212766	2.085106724936158
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.0212766	2.085106724936158
HAMAMY SYNDROME; HMMS	0.0212766	2.085106724936158
#170100 PROLIDASE DEFICIENCY	0.0212766	2.085106724936158
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0212766	2.085106724936158
#607832 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO	0.0212766	2.085106724936158
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.0212766	2.085106724936158
GOODPASTURE SYNDROME	0.0212766	2.085106724936158
NF1-microdeletion syndrome	0.021252794999999998	2.0827738350201415
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.021252794999999998	2.0827738350201415
TUBEROUS SCLEROSIS 2; TSC2	0.021252794999999998	2.0827738350201415
SMITH-KINGSMORE SYNDROME; SKS	0.021252794999999998	2.0827738350201415
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020883310000000002	2.0465643063236847
VAN DEN BOSCH SYNDROME	0.020452395	2.004334637843953
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.020452395	2.004334637843953
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.020452395	2.004334637843953
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.020408199999999998	2.0000035279998727
#162210 NEUROFIBROMATOSIS, FAMILIAL SPINAL;;FSNF	0.020408199999999998	2.0000035279998727
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.020408199999999998	2.0000035279998727
SILVER-RUSSELL SYNDROME; SRS	0.020408199999999998	2.0000035279998727
RUSSELL-SILVER SYNDROME, X-LINKED	0.020408199999999998	2.0000035279998727
BOHRING-OPITZ SYNDROME	0.01978676	1.9391024101923129
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.019778940000000002	1.938336050219902
DOUBLE NAIL FOR FIFTH TOE	0.0196078	1.921564330823684
BEEMER LETHAL MALFORMATION SYNDROME	0.0196078	1.921564330823684
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	1.921564330823684
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	1.921564330823684
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	1.921564330823684
HHHH SYNDROME	0.0196078	1.921564330823684
THALIDOMIDE SUSCEPTIBILITY	0.0196078	1.921564330823684
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	1.921564330823684
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	1.921564330823684
CARPAL DISPLACEMENT	0.0196078	1.921564330823684
MONOPHALANGY OF GREAT TOE	0.0196078	1.921564330823684
KNUCKLE PADS	0.0196078	1.921564330823684
THUMBS, CONGENITAL CLASPED	0.0196078	1.921564330823684
PACHYDERMODACTYLY, FAMILIAL	0.0196078	1.921564330823684
VESICOURETERAL REFLUX 1	0.0196078	1.921564330823684
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	1.921564330823684
RAYNAUD DISEASE	0.0196078	1.921564330823684
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	1.921564330823684
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	1.921564330823684
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	1.921564330823684
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	1.921564330823684
PUBIC BONE DYSPLASIA	0.0196078	1.921564330823684
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	1.921564330823684
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	1.921564330823684
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	1.921564330823684
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	1.921564330823684
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	1.921564330823684
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	1.921564330823684
SPINAL ARACHNOIDITIS	0.0196078	1.921564330823684
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	1.921564330823684
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	1.921564330823684
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	1.921564330823684
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	1.921564330823684
TRACHEOBRONCHOMEGALY	0.0196078	1.921564330823684
BAND HETEROTOPIA; BH	0.0196078	1.921564330823684
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	1.921564330823684
LETTERER-SIWE DISEASE	0.0196078	1.921564330823684
THROMBOCYTOPENIA 3	0.0196078	1.921564330823684
TOE, MISSHAPEN	0.0196078	1.921564330823684
#215300 CHONDROSARCOMA	0.0196078	1.921564330823684
NEPHROSIALIDOSIS	0.0196078	1.921564330823684
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	1.921564330823684
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.019513355000000003	1.912308721156886
WIEACKER-WOLFF SYNDROME	0.018927390000000002	1.8548841532241704
AICARDI SYNDROME; AIC	0.01867658	1.8303047741090281
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.018558395000000002	1.8187226445259848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.01850343	1.8133360747199012
SAY SYNDROME	0.01794842	1.7589450966779763
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.017830235	1.7473629670949329
RENPENNING SYNDROME 1; RENS1	0.017492385000000003	1.714253668286868
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.01729766	1.6951706189738576
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.016802135	1.6466091707220698
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.016296095	1.5970172525073787
EMANUEL SYNDROME	0.016278795	1.595321852568413
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.01581354	1.5497268642098327
LATERAL MENINGOCELE SYNDROME	0.01581354	1.5497268642098327
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.015772050000000003	1.5456608443562097
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.015459320000000002	1.515013305459521
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.015451500000000002	1.51424694548711
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.015451500000000002	1.51424694548711
PETERS-PLUS SYNDROME; PTRPLS	0.0154342	1.5125515455481444
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.015341135	1.5034311758764776
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.01510599	1.480386966706069
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.015098170000000001	1.4796206067336581
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.014778305000000002	1.4482738378621418
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.014743950000000002	1.4449070479833463
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.014736995000000001	1.4442254580078835
KOOLEN-DE VRIES SYNDROME; KDVS	0.014699085	1.44051027814163
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.01459995	1.430795048491378
MARFANOID HYPERMOBILITY SYNDROME	0.01459995	1.430795048491378
#614976 CARPENTER SYNDROME 2; CRPT2	0.01449654	1.4206608688562086
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.01449654	1.4206608688562086
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.014337045	1.4050303594189069
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.01415869	1.3875515700481433
Diamond-Blackfan anemia 1	0.014008835	1.3728657805768318
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.013871790000000002	1.3594353710603266
MUCOPOLYSACCHARIDOSIS TYPE IX	0.013871790000000002	1.3594353710603266
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.013871790000000002	1.3594353710603266
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.013502795000000001	1.323273862362141
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.013502795000000001	1.323273862362141
TYROSINE TRANSAMINASE DEFICIENCY	0.013502795000000001	1.323273862362141
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.013461485	1.3192254825078824
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.013461485	1.3192254825078824
MARSHALL-SMITH SYNDROME; MRSHSS	0.013453665	1.3184591225354714
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.01316424	1.2900954735565628
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.013156420000000002	1.289329113584152
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.013061534999999999	1.280030383918906
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.012795245	1.2539339648583772
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.012757335	1.2502187849921236
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.012757335	1.2502187849921236
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.012757335	1.2502187849921236
COFFIN-SIRIS SYNDROME 6; CSS6	0.012733325	1.247865805076831
BARAITSER-WINTER SYNDROME 2; BRWS2	0.012725505000000002	1.24709944510442
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.012658200000000001	1.240503555341872
PATELLA APLASIA-HYPOPLASIA	0.012658200000000001	1.240503555341872
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.012658200000000001	1.240503555341872
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.012658200000000001	1.240503555341872
131600 EPIDERMOID CYSTS	0.012658200000000001	1.240503555341872
#162091 SCHWANNOMATOSIS;;NEURILEMMOMATOSIS, CONGENITAL CUTANEOUS	0.012658200000000001	1.240503555341872
PRENATAL BOWING	0.012658200000000001	1.240503555341872
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.012658200000000001	1.240503555341872
COMEDONES, FAMILIAL DYSKERATOTIC	0.012658200000000001	1.240503555341872
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.012658200000000001	1.240503555341872
DERMAL RIDGES, PATTERNLESS	0.012658200000000001	1.240503555341872
SYRINGOMAS, MULTIPLE	0.012658200000000001	1.240503555341872
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.012658200000000001	1.240503555341872
PIGMENTED PURPURIC ERUPTION	0.012658200000000001	1.240503555341872
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.012658200000000001	1.240503555341872
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.012658200000000001	1.240503555341872
SPINOCEREBELLAR ATAXIA 34; SCA34	0.012658200000000001	1.240503555341872
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.012658200000000001	1.240503555341872
PARANA HARD-SKIN SYNDROME	0.012658200000000001	1.240503555341872
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.012658200000000001	1.240503555341872
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.012658200000000001	1.240503555341872
LICHEN PLANUS, FAMILIAL	0.012658200000000001	1.240503555341872
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.012658200000000001	1.240503555341872
PSEUDOATROPHODERMA COLLI	0.012658200000000001	1.240503555341872
#300299 NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX;;XLN	0.012658200000000001	1.240503555341872
DERMATOSIS PAPULOSA NIGRA	0.012658200000000001	1.240503555341872
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.012658200000000001	1.240503555341872
PILONIDAL SINUS	0.012658200000000001	1.240503555341872
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.012658200000000001	1.240503555341872
KYRLE DISEASE	0.012658200000000001	1.240503555341872
FUTCHER LINE	0.012658200000000001	1.240503555341872
PERIODONTITIS, AGGRESSIVE, 1	0.012658200000000001	1.240503555341872
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.012658200000000001	1.240503555341872
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.012658200000000001	1.240503555341872
TRICHILEMMAL CYST 1	0.012658200000000001	1.240503555341872
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.012658200000000001	1.240503555341872
GLOMUVENOUS MALFORMATIONS	0.012658200000000001	1.240503555341872
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.012658200000000001	1.240503555341872
SIMOSA CRANIOFACIAL SYNDROME	0.012658200000000001	1.240503555341872
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.012658200000000001	1.240503555341872
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.012658200000000001	1.240503555341872
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.012658200000000001	1.240503555341872
INSECT STINGS, HYPERSENSITIVITY TO	0.012658200000000001	1.240503555341872
CALLOSITIES, HEREDITARY PAINFUL	0.012658200000000001	1.240503555341872
LENTIGINES	0.012658200000000001	1.240503555341872
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.012658200000000001	1.240503555341872
KERATOSIS, FAMILIAL ACTINIC	0.012658200000000001	1.240503555341872
CURRY-JONES SYNDROME	0.012658200000000001	1.240503555341872
ACROMIAL DIMPLES	0.012658200000000001	1.240503555341872
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.012658200000000001	1.240503555341872
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.012658200000000001	1.240503555341872
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.012658200000000001	1.240503555341872
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.012658200000000001	1.240503555341872
FASCIAL DYSTROPHY, CONGENITAL	0.012658200000000001	1.240503555341872
CAROTENEMIA, FAMILIAL	0.012658200000000001	1.240503555341872
SHORT SYNDROME	0.012658200000000001	1.240503555341872
LOEYS-DIETZ SYNDROME 3; LDS3	0.01261689	1.2364551754876136
PALLISTER-KILLIAN SYNDROME	0.012216939999999999	1.197260076898637
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.01195065	1.1711636578381082
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.01191274	1.1674484779718548
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.01191274	1.1674484779718548
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.011897965	1.166000528023981
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.011897965	1.166000528023981
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.011897965	1.166000528023981
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.011897965	1.166000528023981
LOEYS-DIETZ SYNDROME 5	0.01188873	1.165095498056562
Orofaciodigital syndrome XVII	0.011880910000000001	1.1643291380841512
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.011873955000000002	1.1636475481086883
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.011873955	1.1636475481086883
SCHAAF-YANG SYNDROME; SHFYNG	0.011873955	1.1636475481086883
CHROMOSOME 17q12 DELETION SYNDROME	0.011873955	1.1636475481086883
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.011543745000000001	1.1312869692736691
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.011543745	1.131286969273669
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.011543745	1.131286969273669
FEINGOLD SYNDROME 1; FGLDS1	0.011535925	1.130520609301258
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.011519735	1.1289339893583763
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.011511915000000001	1.1281676293859653
AYME-GRIPP SYNDROME; AYGRP	0.011474005	1.124452449519712
SIFRIM-HITZ-WEISS SYNDROME	0.011474005	1.124452449519712
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.01136539	1.1138081799029054
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.011207715	1.0983560304591826
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.011207715	1.0983560304591826
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.011207715	1.0983560304591826
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.011207715	1.0983560304591826
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.011207715	1.0983560304591826
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.011207715	1.0983560304591826
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.011207715	1.0983560304591826
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.011207715	1.0983560304591826
SECKEL SYNDROME 5; SCKL5	0.011207715	1.0983560304591826
VELOCARDIOFACIAL SYNDROME	0.011207715	1.0983560304591826
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.011207715	1.0983560304591826
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.01109128	1.0869454008699655
C SYNDROME	0.01105337	1.083230221003712
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.01105337	1.083230221003712
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.01102936	1.0808772410884193
COFFIN-SIRIS SYNDROME 1; CSS1	0.010869865000000001	1.0652467316511176
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.010869865000000001	1.0652467316511176
YUNIS-VARON SYNDROME	0.01069133	1.047750302280989
KLEEFSTRA SYNDROME	0.01069133	1.047750302280989
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.010684375	1.0470687123055262
OROFACIODIGITAL SYNDROME X	0.01067514	1.0461636823381073
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.01067514	1.0461636823381073
MESOMELIC LIMB SHORTENING AND BOWING	0.01067514	1.0461636823381073
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.010660365000000002	1.0447157323902339
SHASHI-PENA SYNDROME; SHAPNS	0.010660365000000002	1.0447157323902339
WEAVER SYNDROME	0.010660365000000002	1.0447157323902339
COHEN-GIBSON SYNDROME; COGIS	0.010660365000000002	1.0447157323902339
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.010660365000000002	1.0447157323902339
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.010637230000000001	1.042448502471854
260150 PALANT CLEFT PALATE SYNDROME	0.010637230000000001	1.042448502471854
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.010622455	1.04100055252398
SECKEL SYNDROME 4	0.010363120000000002	1.015585723438914
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.010363120000000002	1.015585723438914
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.01036312	1.0155857234389138
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.010268235	1.0062869937736683
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.010260415	1.0055206338012572
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.010260415	1.0055206338012572
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.010025270000000001	0.9824764246308487
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.009994125000000001	0.9794242147407283
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.009994125000000001	0.9794242147407283
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.009994125000000001	0.9794242147407283
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.009956215000000001	0.9757090348744748
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.009956215000000001	0.9757090348744748
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.009956215000000001	0.9757090348744748
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.009956215000000001	0.9757090348744748
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.009956215000000001	0.9757090348744748
NEMALINE MYOPATHY 3; NEM3	0.009815770000000001	0.9619454253699647
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.009815770000000001	0.9619454253699647
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.009815770000000001	0.9619454253699647
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00977786	0.9582302455037109
HUNTER-MACDONALD SYNDROME	0.00977786	0.9582302455037109
PRADER-WILLI SYNDROME; PWS	0.00977786	0.9582302455037109
MENTAL RETARDATION, X-LINKED 102	0.009656275	0.946314915932663
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.009594355	0.9402467561511166
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00942364	0.9235166867533993
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.00941582	0.9227503267809881
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.00941582	0.9227503267809881
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.009408864999999999	0.9220687368055253
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.009408864999999999	0.9220687368055253
HAREL-YOON SYNDROME; HAYOS	0.009408864999999999	0.9220687368055253
CHROMOSOME 9P DELETION SYNDROME	0.009408864999999999	0.9220687368055253
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.009408864999999999	0.9220687368055253
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.009408864999999999	0.9220687368055253
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.009408864999999999	0.9220687368055253
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.009149530000000001	0.8966539077204594
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.009149530000000001	0.8966539077204594
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.009149530000000001	0.8966539077204594
GAUCHER DISEASE, PERINATAL LETHAL	0.009149530000000001	0.8966539077204594
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.009149530000000001	0.8966539077204594
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.009149530000000001	0.8966539077204594
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.009149530000000001	0.8966539077204594
LAMBOTTE SYNDROME	0.009149530000000001	0.8966539077204594
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.009149530000000001	0.8966539077204594
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.009149530000000001	0.8966539077204594
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00911162	0.8929387278542058
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00911162	0.8929387278542058
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00911162	0.8929387278542058
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00911162	0.8929387278542058
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00911162	0.8929387278542058
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00911162	0.8929387278542058
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00911162	0.8929387278542058
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.00911162	0.8929387278542058
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.009087610000000001	0.8905857479389131
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.009087610000000001	0.8905857479389131
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.008928115	0.8749552385016114
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.008928115	0.8749552385016114
OROFACIODIGITAL SYNDROME I; OFD1	0.008928115	0.8749552385016114
#300867 KABUKI SYNDROME 2; KABUK2	0.008928115	0.8749552385016114
MEIER-GORLIN SYNDROME 7	0.00874976	0.8574764491308479
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.008742625	0.8567772191560201
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.008742625	0.8567772191560201
HOLOPROSENCEPHALY 5; HPE5	0.008742625	0.8567772191560201
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.008742625	0.8567772191560201
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.008742625	0.8567772191560201
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.008742625	0.8567772191560201
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.008742625	0.8567772191560201
FRONTONASAL DYSPLASIA 2; FND2	0.008742625	0.8567772191560201
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.008718615	0.8544242392407274
Jawad syndrome	0.008718615	0.8544242392407274
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.008718615	0.8544242392407274
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.008718615	0.8544242392407274
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.008718615	0.8544242392407274
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.008718615	0.8544242392407274
MENTAL RETARDATION, X-LINKED 104; MRX104	0.008718615	0.8544242392407274
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.008718615	0.8544242392407274
Bangstad syndrome	0.008718615	0.8544242392407274
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.008718615	0.8544242392407274
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.008718615	0.8544242392407274
MICROPHTHALMIA, SYNDROMIC 12	0.008718615	0.8544242392407274
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.008718615	0.8544242392407274
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.008680705	0.8507090593744737
MCDONOUGH SYNDROME	0.008680705	0.8507090593744737
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.008680705	0.8507090593744737
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.008380765	0.8213149404326621
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.008380765	0.8213149404326621
FOCAL DERMAL HYPOPLASIA; FDH	0.008076564999999999	0.7915033415058794
CHROMOSOME 18Q DELETION SYNDROME	0.008076564999999999	0.7915033415058794
COFFIN-SIRIS SYNDROME 4; CSS4	0.008068745	0.7907369815334686
Pierpont syndrome	0.008068745	0.7907369815334686
COFFIN-SIRIS SYNDROME 3; CSS3	0.008068745	0.7907369815334686
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.008068745	0.7907369815334686
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00789803	0.7740069121357511
VERVERI-BRADY SYNDROME; VERBRAS	0.00789803	0.7740069121357511
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00789803	0.7740069121357511
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00789803	0.7740069121357511
PITT-HOPKINS SYNDROME	0.00789803	0.7740069121357511
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00789803	0.7740069121357511
PSEUDOTRISOMY 13 SYNDROME	0.00789803	0.7740069121357511
PEHO-LIKE SYNDROME; PEHOL	0.00787402	0.7716539322204584
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00787402	0.7716539322204584
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00787402	0.7716539322204584
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00787402	0.7716539322204584
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00787402	0.7716539322204584
WEBB-DATTANI SYNDROME; WEDAS	0.00787402	0.7716539322204584
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00787402	0.7716539322204584
#602588 BRANCHIOOTIC SYNDROME 1; BOS1;;BO SYNDROME 1;;BRANCHIOOTIC DYSPLASIAANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED	0.00787402	0.7716539322204584
WT LIMB-BLOOD SYNDROME	0.00787402	0.7716539322204584
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00787402	0.7716539322204584
MYOPATHY, CENTRONUCLEAR, 5	0.00787402	0.7716539322204584
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00787402	0.7716539322204584
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00787402	0.7716539322204584
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.00787402	0.7716539322204584
MARFAN SYNDROME; MFS	0.00787402	0.7716539322204584
GABA-TRANSAMINASE DEFICIENCY	0.00787402	0.7716539322204584
PEHO SYNDROME; PEHO	0.00787402	0.7716539322204584
#615706 AURICULOCONDYLAR SYNDROME 3; ARCND3	0.00787402	0.7716539322204584
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.00787402	0.7716539322204584
KAGAMI-OGATA SYNDROME	0.00787402	0.7716539322204584
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00787402	0.7716539322204584
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00787402	0.7716539322204584
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00787402	0.7716539322204584
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00787402	0.7716539322204584
HYPOGLOSSIA-HYPODACTYLIA	0.00787402	0.7716539322204584
%613857 OROFACIAL CLEFT 13; OFC13	0.00787402	0.7716539322204584
CRANIOSYNOSTOSIS 4; CRS4	0.00787402	0.7716539322204584
LETHAL CONGENITAL CONTRACTURE SYNDROME 11; LCCS11	0.00787402	0.7716539322204584
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00787402	0.7716539322204584
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00787402	0.7716539322204584
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00783611	0.7679387523542048
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.00783611	0.7679387523542048
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00783611	0.7679387523542048
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00783611	0.7679387523542048
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.00783611	0.7679387523542048
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.00783611	0.7679387523542048
HYPERTELORISM, TEEBI TYPE; TBHS	0.00783611	0.7679387523542048
MEIER-GORLIN SYNDROME 1; MGORS1	0.007714525000000001	0.7560234227831568
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.007652605000000001	0.7499552630016105
3MC SYNDROME 3	0.007652605000000001	0.7499552630016105
CORNELIA DE LANGE SYNDROME 3	0.007652605000000001	0.7499552630016105
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00753617	0.7385446334123931
CLEIDOCRANIAL DYSPLASIA; CCD	0.00753617	0.7385446334123931
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00753617	0.7385446334123931
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00753617	0.7385446334123931
IMMUNODEFICIENCY 49; IMD49	0.007467115	0.7317772436560191
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.007467115	0.7317772436560191
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.007467115	0.7317772436560191
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.007467115	0.7317772436560191
XIA-GIBBS SYNDROME	0.007467115	0.7317772436560191
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.007467115	0.7317772436560191
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.007467115	0.7317772436560191
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.007467115	0.7317772436560191
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.007467115	0.7317772436560191
MENTAL RETARDATION, X-LINKED 90	0.007467115	0.7317772436560191
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007467115	0.7317772436560191
POTOCKI-LUPSKI SYNDROME	0.007224150000000001	0.7079666745131998
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.006869930000000001	0.6732531157628878
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.006869930000000001	0.6732531157628878
CHARGE SYNDROME	0.006862975	0.6725715257874251
MARDEN-WALKER SYNDROME	0.006862975	0.6725715257874251
SECKEL SYNDROME 1; SCKL1	0.006862975	0.6725715257874251
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.006855155000000001	0.671805165815014
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.006855155000000001	0.671805165815014
CHARGE-LIKE SYNDROME, X-LINKED	0.006808010000000001	0.6671849559813415
RAPADILINO SYNDROME	0.006808010000000001	0.6671849559813415
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.006808010000000001	0.6671849559813415
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.006808010000000001	0.6671849559813415
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.006808010000000001	0.6671849559813415
ZTTK SYNDROME; ZTTKS	0.006801055	0.6665033660058788
#150250 LARSEN SYNDROME; LRS	0.006801055	0.6665033660058788
SMITH-MAGENIS SYNDROME; SMS	0.006793235000000001	0.6657370060334679
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.006793235000000001	0.6657370060334679
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.006793235000000001	0.6657370060334679
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.006793235000000001	0.6657370060334679
RAMON SYNDROME	0.006793235	0.6657370060334677
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.00662252	0.6490069366357502
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.00662252	0.6490069366357502
CHROMOSOME 16Q22 DELETION SYNDROME	0.00662252	0.6490069366357502
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00662252	0.6490069366357502
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.00662252	0.6490069366357502
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00662252	0.6490069366357502
OROFACIAL CLEFT 15	0.00662252	0.6490069366357502
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00662252	0.6490069366357502
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00662252	0.6490069366357502
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.00662252	0.6490069366357502
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00662252	0.6490069366357502
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.00662252	0.6490069366357502
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00662252	0.6490069366357502
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00662252	0.6490069366357502
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00662252	0.6490069366357502
SCHOLTE SYNDROME; SHLTS	0.00662252	0.6490069366357502
FRONTOOCULAR SYNDROME	0.00662252	0.6490069366357502
ALAGILLE SYNDROME 1; ALGS1	0.00662252	0.6490069366357502
HOLOPROSENCEPHALY 7	0.00662252	0.6490069366357502
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00662252	0.6490069366357502
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00662252	0.6490069366357502
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00662252	0.6490069366357502
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00662252	0.6490069366357502
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.006439015	0.6310234472831558
ACROCALLOSAL SYNDROME; ACLS	0.006439015	0.6310234472831558
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.006439015	0.6310234472831558
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.006439015	0.6310234472831558
3MC SYNDROME 2	0.006439015	0.6310234472831558
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.006439015	0.6310234472831558
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.006134815	0.6012118483563733
GLASS SYNDROME	0.006134815	0.6012118483563733
Mental retardation, autosomal dominant 21	0.006134815	0.6012118483563733
OCULOPALATOCEREBRAL SYNDROME	0.006134815	0.6012118483563733
DESBUQUOIS DYSPLASIA 2; DBQD2	0.006134815	0.6012118483563733
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.006134815	0.6012118483563733
CHROMOSOME 1p35 DELETION SYNDROME	0.006126995000000001	0.6004454883839625
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.006126995000000001	0.6004454883839625
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.006126995000000001	0.6004454883839625
PELIZAEUS-MERZBACHER DISEASE	0.006126995000000001	0.6004454883839625
OPTIC ATROPHY 11; OPA11	0.006126995000000001	0.6004454883839625
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.00601838	0.5898012187671561
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.00601838	0.5898012187671561
NEU-LAXOVA SYNDROME 2; NLS2	0.00601838	0.5898012187671561
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00601838	0.5898012187671561
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.006010560000000001	0.5890348587947452
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.006010560000000001	0.5890348587947452
XFE PROGEROID SYNDROME; XFEPS	0.006010560000000001	0.5890348587947452
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.006010560000000001	0.5890348587947452
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00595646	0.5837330589856099
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00595646	0.5837330589856099
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00595646	0.5837330589856099
Aarskog-Scott syndrome	0.00595646	0.5837330589856099
TEMPLE SYNDROME	0.00595646	0.5837330589856099
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00595646	0.5837330589856099
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00595646	0.5837330589856099
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00595646	0.5837330589856099
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00595646	0.5837330589856099
DIGEORGE SYNDROME; DGS	0.00595646	0.5837330589856099
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.005948640000000001	0.5829666990131989
LYMPHEDEMA, HEREDITARY, III	0.005948640000000001	0.5829666990131989
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.005948640000000001	0.5829666990131989
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00594864	0.5829666990131988
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00559442	0.548253140262887
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00559442	0.548253140262887
HARDIKAR SYNDROME	0.00559442	0.548253140262887
SWEENEY-COX SYNDROME; SWCOS	0.00559442	0.548253140262887
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.00559442	0.548253140262887
CAMPOMELIC DYSPLASIA	0.00559442	0.548253140262887
BASAL CELL NEVUS SYNDROME	0.005587465	0.5475715502874241
AU-KLINE SYNDROME; AUKS	0.005587465	0.5475715502874241
OROFACIODIGITAL SYNDROME V; OFD5	0.005587465	0.5475715502874241
COWDEN SYNDROME 6; CWS6	0.005579645	0.5468051903150131
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.005579645	0.5468051903150131
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.005579645	0.5468051903150131
COWDEN SYNDROME 5; CWS5	0.005579645	0.5468051903150131
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.00529022	0.5184415413361044
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00529022	0.5184415413361044
TEEBI-SHALTOUT SYNDROME; TBSH	0.00529022	0.5184415413361044
OROFACIODIGITAL SYNDROME IX; OFD9	0.00529022	0.5184415413361044
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00529022	0.5184415413361044
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00529022	0.5184415413361044
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00529022	0.5184415413361044
RAINE SYNDROME	0.00529022	0.5184415413361044
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.005282400000000001	0.5176751813636936
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.005282400000000001	0.5176751813636936
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.005282400000000001	0.5176751813636936
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.005282400000000001	0.5176751813636936
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.005282400000000001	0.5176751813636936
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.005282400000000001	0.5176751813636936
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.005275445	0.5169935913882308
COFFIN-LOWRY SYNDROME; CLS	0.005275445	0.5169935913882308
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.005275445	0.5169935913882308
MARINESCO-SJOGREN SYNDROME; MSS	0.005275445	0.5169935913882308
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.005275445	0.5169935913882308
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.005275445	0.5169935913882308
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.005275445	0.5169935913882308
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.005275445	0.5169935913882308
RUVALCABA SYNDROME	0.005275445	0.5169935913882308
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.005275445	0.5169935913882308
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.005275445	0.5169935913882308
CEREBELLOFACIODENTAL SYNDROME	0.005275445	0.5169935913882308
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.005275445	0.5169935913882308
ASPARTYLGLUCOSAMINURIA; AGU	0.005275445	0.5169935913882308
#278250 WRINKLY SKIN SYNDROME; WSS	0.005275445	0.5169935913882308
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.0049212249999999996	0.4822800326379187
LOWRY-MACLEAN SYNDROME	0.0049212249999999996	0.4822800326379187
ADAMS-OLIVER SYNDROME 1; AOS1	0.0049212249999999996	0.4822800326379187
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.0049212249999999996	0.4822800326379187
MEIER-GORLIN SYNDROME 6; MGORS6	0.0049212249999999996	0.4822800326379187
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0049212249999999996	0.4822800326379187
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0049212249999999996	0.4822800326379187
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0049212249999999996	0.4822800326379187
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.004913405000000001	0.4815136726655078
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.004913405000000001	0.4815136726655078
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.004913405000000001	0.4815136726655078
CYCLIC VOMITING SYNDROME	0.004913405000000001	0.4815136726655078
WARSAW BREAKAGE SYNDROME; WABS	0.004913405000000001	0.4815136726655078
MICROPHTHALMIA, SYNDROMIC 1	0.004913405000000001	0.4815136726655078
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.0048593049999999995	0.4762118728563725
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0048593049999999995	0.4762118728563725
OROFACIODIGITAL SYNDROME VI	0.0048593049999999995	0.4762118728563725
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.0048593049999999995	0.4762118728563725
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.0048593049999999995	0.4762118728563725
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.0048593049999999995	0.4762118728563725
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.0048593049999999995	0.4762118728563725
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.0048593049999999995	0.4762118728563725
2q33.1 deletion syndrome	0.0048593049999999995	0.4762118728563725
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.0048593049999999995	0.4762118728563725
PRIMROSE SYNDROME; PRIMS	0.004851485000000001	0.47544551288396153
CHOPS SYNDROME; CHOPS	0.004851485000000001	0.47544551288396153
COFFIN-SIRIS SYNDROME 7; CSS7	0.004851485000000001	0.47544551288396153
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.004851485000000001	0.47544551288396153
OHDO SYNDROME	0.004851485000000001	0.47544551288396153
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.00474287	0.4648012432671551
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00474287	0.4648012432671551
NEMALINE MYOPATHY 2; NEM2	0.00474287	0.4648012432671551
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.00474287	0.4648012432671551
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00474287	0.4648012432671551
STICKLER SYNDROME, TYPE I	0.00474287	0.4648012432671551
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00474287	0.4648012432671551
#615731 NEMALINE MYOPATHY 9; NEM9	0.00474287	0.4648012432671551
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00474287	0.4648012432671551
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B; CPSKF1B	0.00474287	0.4648012432671551
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00474287	0.4648012432671551
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00474287	0.4648012432671551
FACIOCARDIORENAL SYNDROME	0.00474287	0.4648012432671551
ZIMMERMANN-LABAND SYNDROME 1	0.00473505	0.4640348832947442
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00473505	0.4640348832947442
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00473505	0.4640348832947442
IVIC SYNDROME	0.00473505	0.4640348832947442
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.00473505	0.4640348832947442
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.00473505	0.4640348832947442
MORQUIO SYNDROME A	0.00473505	0.4640348832947442
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00473505	0.4640348832947442
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00473505	0.4640348832947442
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.00473505	0.4640348832947442
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.00473505	0.4640348832947442
BRITTLE CORNEA SYNDROME	0.00473505	0.4640348832947442
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00473505	0.4640348832947442
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.00443085	0.4342232843679617
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00443085	0.4342232843679617
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00443085	0.4342232843679617
OGDEN SYNDROME; OGDNS	0.00443085	0.4342232843679617
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00443085	0.4342232843679617
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00443085	0.4342232843679617
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.00443085	0.4342232843679617
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.0040766299999999995	0.3995097256176498
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0040766299999999995	0.3995097256176498
3MC SYNDROME 1	0.0040766299999999995	0.3995097256176498
#256520 NEU-LAXOVA SYNDROME; NLS	0.0040766299999999995	0.3995097256176498
VICI SYNDROME; VICIS	0.0040766299999999995	0.3995097256176498
#602398 DESMOSTEROLOSIS	0.0040766299999999995	0.3995097256176498
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0040766299999999995	0.3995097256176498
STROMME SYNDROME; STROMS	0.0040766299999999995	0.3995097256176498
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.0040766299999999995	0.3995097256176498
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.0040766299999999995	0.3995097256176498
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0040766299999999995	0.3995097256176498
ADDUCTED THUMBS SYNDROME	0.0040766299999999995	0.3995097256176498
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0040766299999999995	0.3995097256176498
MECKEL SYNDROME, TYPE 4; MKS4	0.0040766299999999995	0.3995097256176498
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.0040766299999999995	0.3995097256176498
HARTSFIELD SYNDROME; HRTFDS	0.0040766299999999995	0.3995097256176498
MECKEL SYNDROME, TYPE 1; MKS1	0.0040766299999999995	0.3995097256176498
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0040766299999999995	0.3995097256176498
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.0040766299999999995	0.3995097256176498
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0040766299999999995	0.3995097256176498
XYLOSIDASE DEFICIENCY	0.004068810000000001	0.3987433656452388
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.004068810000000001	0.3987433656452388
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.004068810000000001	0.3987433656452388
YOU-HOOVER-FONG SYNDROME; YHFS	0.004068810000000001	0.3987433656452388
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.004068810000000001	0.3987433656452388
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.004068810000000001	0.3987433656452388
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.004068810000000001	0.3987433656452388
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.004068810000000001	0.3987433656452388
PHELAN-MCDERMID SYNDROME; PHMDS	0.004068810000000001	0.3987433656452388
GENITOPATELLAR SYNDROME; GTPTS	0.004068810000000001	0.3987433656452388
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004068810000000001	0.3987433656452388
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.004068810000000001	0.3987433656452388
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.004061855	0.39806177566977596
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.004061855	0.39806177566977596
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.004061855	0.39806177566977596
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.004061855	0.39806177566977596
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.004061855	0.39806177566977596
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.004061855	0.39806177566977596
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004061855	0.39806177566977596
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004061855	0.39806177566977596
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.004061855	0.39806177566977596
Congenital disorder of glycosylation, type IIh	0.004061855	0.39806177566977596
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004061855	0.39806177566977596
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.004061855	0.39806177566977596
JABERI-ELAHI SYNDROME; JABELS	0.004061855	0.39806177566977596
BETA-UREIDOPROPIONASE DEFICIENCY	0.004061855	0.39806177566977596
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.004061855	0.39806177566977596
HALLERMANN-STREIFF SYNDROME; HSS	0.004061855	0.39806177566977596
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.004061855	0.39806177566977596
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.004061855	0.39806177566977596
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.004061855	0.39806177566977596
KLEEFSTRA SYNDROME 2; KLEFS2	0.004061855	0.39806177566977596
HOLOPROSENCEPHALY 2; HPE2	0.004061855	0.39806177566977596
TYSHCHENKO SYNDROME	0.0040147099999999995	0.3934415658361035
LARSEN-LIKE SYNDROME	0.0040147099999999995	0.3934415658361035
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.0040147099999999995	0.3934415658361035
OROFACIODIGITAL SYNDROME VIII; OFD8	0.0040147099999999995	0.3934415658361035
DIAMOND-BLACKFAN ANEMIA 10	0.0040147099999999995	0.3934415658361035
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0040147099999999995	0.3934415658361035
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.0040147099999999995	0.3934415658361035
OROFACIODIGITAL SYNDROME IV; OFD4	0.0040147099999999995	0.3934415658361035
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0040147099999999995	0.3934415658361035
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.0040147099999999995	0.3934415658361035
CULLER-JONES SYNDROME; CJS	0.0040147099999999995	0.3934415658361035
#154780 MARSHALL SYNDROME; MRSHS	0.0040147099999999995	0.3934415658361035
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.0040147099999999995	0.3934415658361035
CHROMOSOME 15q25 DELETION SYNDROME	0.0040147099999999995	0.3934415658361035
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.0040147099999999995	0.3934415658361035
ACROCRANIOFACIAL DYSOSTOSIS	0.0040147099999999995	0.3934415658361035
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.0040147099999999995	0.3934415658361035
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.0040147099999999995	0.3934415658361035
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.004006890000000001	0.39267520586369264
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.004006890000000001	0.39267520586369264
COXOAURICULAR SYNDROME	0.004006890000000001	0.39267520586369264
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.004006890000000001	0.39267520586369264
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.004006890000000001	0.39267520586369264
SPASTIC PARAPARESIS AND DEAFNESS	0.004006890000000001	0.39267520586369264
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.004006890000000001	0.39267520586369264
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.004006890000000001	0.39267520586369264
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.004006890000000001	0.39267520586369264
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.003999935	0.3919936158882298
LOWE OCULOCEREBRORENAL SYNDROME	0.003999935	0.3919936158882298
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.003999935	0.3919936158882298
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.003999935	0.3919936158882298
MUCOLIPIDOSIS III ALPHA/BETA	0.003999935	0.3919936158882298
CODAS SYNDROME	0.003999935	0.3919936158882298
OROFACIODIGITAL SYNDROME XI; OFD11	0.003645715	0.3572800571379179
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.003645715	0.3572800571379179
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.003645715	0.3572800571379179
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.003645715	0.3572800571379179
ZUNICH NEUROECTODERMAL SYNDROME	0.003645715	0.3572800571379179
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.003645715	0.3572800571379179
FRYNS SYNDROME; FRNS	0.003645715	0.3572800571379179
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.003645715	0.3572800571379179
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.003645715	0.3572800571379179
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.003645715	0.3572800571379179
HEMIFACIAL MICROSOMIA	0.003645715	0.3572800571379179
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.003645715	0.3572800571379179
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.003645715	0.3572800571379179
ZECHI-CEIDE SYNDROME	0.003645715	0.3572800571379179
CEREBROOCULONASAL SYNDROME	0.003645715	0.3572800571379179
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.003645715	0.3572800571379179
OCULOCEREBROCUTANEOUS SYNDROME	0.003645715	0.3572800571379179
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.003645715	0.3572800571379179
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.0036378950000000004	0.3565136971655069
BARDET-BIEDL SYNDROME 16; BBS16	0.0036378950000000004	0.3565136971655069
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.0036378950000000004	0.3565136971655069
CONE-ROD DYSTROPHY 1; CORD1	0.0036378950000000004	0.3565136971655069
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.0036378950000000004	0.3565136971655069
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0036378950000000004	0.3565136971655069
HYDROXYKYNURENINURIA	0.0036378950000000004	0.3565136971655069
LISSENCEPHALY 5; LIS5	0.0036378950000000004	0.3565136971655069
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.0036378950000000004	0.3565136971655069
RICHARDS-RUNDLE SYNDROME; RRNS	0.0036378950000000004	0.3565136971655069
FETAL IODINE DEFICIENCY DISORDER	0.0036378950000000004	0.3565136971655069
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.0036378950000000004	0.3565136971655069
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.0036378950000000004	0.3565136971655069
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0036378950000000004	0.3565136971655069
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.0036378950000000004	0.3565136971655069
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0036378950000000004	0.3565136971655069
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0036378950000000004	0.3565136971655069
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0036378950000000004	0.3565136971655069
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.0036378950000000004	0.3565136971655069
COWCHOCK SYNDROME; COWCK	0.0036378950000000004	0.3565136971655069
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.0036378950000000004	0.3565136971655069
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0036378950000000004	0.3565136971655069
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0036378950000000004	0.3565136971655069
DYSOSTEOSCLEROSIS	0.0036378950000000004	0.3565136971655069
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.0036378950000000004	0.3565136971655069
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0036378950000000004	0.3565136971655069
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0036378950000000004	0.3565136971655069
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.0036378950000000004	0.3565136971655069
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0036378950000000004	0.3565136971655069
BARBER-SAY SYNDROME; BBRSAY	0.0036378950000000004	0.3565136971655069
Muenke syndrome	0.0036378950000000004	0.3565136971655069
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0036378950000000004	0.3565136971655069
SPINOCEREBELLAR ATAXIA 13	0.0036378950000000004	0.3565136971655069
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0033336950000000002	0.3267020982387245
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.0033336950000000002	0.3267020982387245
HADZISELIMOVIC SYNDROME	0.0033336950000000002	0.3267020982387245
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.0033336950000000002	0.3267020982387245
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0033336950000000002	0.3267020982387245
CHROMOSOME Xp11.3 DELETION SYNDROME	0.0033336950000000002	0.3267020982387245
MASA SYNDROME	0.0033336950000000002	0.3267020982387245
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0033336950000000002	0.3267020982387245
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0033336950000000002	0.3267020982387245
ALAZAMI-YUAN SYNDROME	0.0033336950000000002	0.3267020982387245
SECKEL SYNDROME 8; SCKL8	0.0033336950000000002	0.3267020982387245
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.0033336950000000002	0.3267020982387245
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0033336950000000002	0.3267020982387245
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.0033336950000000002	0.3267020982387245
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0033336950000000002	0.3267020982387245
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0033336950000000002	0.3267020982387245
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0033336950000000002	0.3267020982387245
WARBURG MICRO SYNDROME 1	0.0033336950000000002	0.3267020982387245
INCONTINENTIA PIGMENTI; IP	0.0033336950000000002	0.3267020982387245
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.0033336950000000002	0.3267020982387245
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.0033336950000000002	0.3267020982387245
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0033336950000000002	0.3267020982387245
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.0033336950000000002	0.3267020982387245
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0033336950000000002	0.3267020982387245
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0033336950000000002	0.3267020982387245
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.0033336950000000002	0.3267020982387245
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.0033336950000000002	0.3267020982387245
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0033336950000000002	0.3267020982387245
COFFIN-SIRIS SYNDROME 5	0.0033336950000000002	0.3267020982387245
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0033336950000000002	0.3267020982387245
#614728 SECKEL SYNDROME 6; SCKL6	0.0033336950000000002	0.3267020982387245
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0033336950000000002	0.3267020982387245
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.0033336950000000002	0.3267020982387245
FEINGOLD SYNDROME 2; FGLDS2	0.0033336950000000002	0.3267020982387245
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0033336950000000002	0.3267020982387245
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.0033336950000000002	0.3267020982387245
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0033336950000000002	0.3267020982387245
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0033336950000000002	0.3267020982387245
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.0033336950000000002	0.3267020982387245
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.0033336950000000002	0.3267020982387245
WHITE-SUTTON SYNDROME; WHSUS	0.0033336950000000002	0.3267020982387245
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0033336950000000002	0.3267020982387245
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0033336950000000002	0.3267020982387245
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.0033336950000000002	0.3267020982387245
AL KAISSI SYNDROME; ALKAS	0.0033336950000000002	0.3267020982387245
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0033336950000000002	0.3267020982387245
15q24 recurrent microdeletion syndrome	0.0033336950000000002	0.3267020982387245
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0033336950000000002	0.3267020982387245
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0033336950000000002	0.3267020982387245
MENKES DISEASE	0.0033336950000000002	0.3267020982387245
HOLOPROSENCEPHALY 1; HPE1	0.0033336950000000002	0.3267020982387245
COHEN SYNDROME	0.0033336950000000002	0.3267020982387245
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.0033336950000000002	0.3267020982387245
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0033336950000000002	0.3267020982387245
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.0033336950000000002	0.3267020982387245
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0033336950000000002	0.3267020982387245
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00321726	0.3152914686495071
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00321726	0.3152914686495071
CRANIOSYNOSTOSIS 6; CRS6	0.00321726	0.3152914686495071
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.00321726	0.3152914686495071
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00321726	0.3152914686495071
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.00321726	0.3152914686495071
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00321726	0.3152914686495071
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00321726	0.3152914686495071
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00321726	0.3152914686495071
ALAZAMI SYNDROME; ALAZS	0.00321726	0.3152914686495071
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00321726	0.3152914686495071
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00321726	0.3152914686495071
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00321726	0.3152914686495071
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00321726	0.3152914686495071
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00321726	0.3152914686495071
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00321726	0.3152914686495071
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00321726	0.3152914686495071
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00321726	0.3152914686495071
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00321726	0.3152914686495071
ALLAN-HERNDON-DUDLEY SYNDROME	0.00321726	0.3152914686495071
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00321726	0.3152914686495071
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00321726	0.3152914686495071
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.00315534	0.30922330886796084
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00315534	0.30922330886796084
ATKIN-FLAITZ SYNDROME	0.00315534	0.30922330886796084
#259450 BRUCK SYNDROME 1; BRKS1	0.00315534	0.30922330886796084
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.00315534	0.30922330886796084
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00315534	0.30922330886796084
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00315534	0.30922330886796084
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00315534	0.30922330886796084
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00315534	0.30922330886796084
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00315534	0.30922330886796084
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00315534	0.30922330886796084
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00315534	0.30922330886796084
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00315534	0.30922330886796084
OSTEOGENESIS IMPERFECTA, TYPE X	0.00315534	0.30922330886796084
RETT SYNDROME; RTT	0.00315534	0.30922330886796084
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.00315534	0.30922330886796084
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00315534	0.30922330886796084
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00315534	0.30922330886796084
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00315534	0.30922330886796084
MUCOLIPIDOSIS III GAMMA	0.00315534	0.30922330886796084
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00315534	0.30922330886796084
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00315534	0.30922330886796084
MIRAGE SYNDROME; MIRAGE	0.00315534	0.30922330886796084
NOONAN SYNDROME 4; NS4	0.00315534	0.30922330886796084
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00315534	0.30922330886796084
STUVE-WIEDEMANN SYNDROME	0.00315534	0.30922330886796084
MACS SYNDROME	0.00315534	0.30922330886796084
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00315534	0.30922330886796084
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.00315534	0.30922330886796084
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00315534	0.30922330886796084
STEEL SYNDROME; STLS	0.00315534	0.30922330886796084
POPOV-CHANG SYNDROME; POPCHAS	0.00315534	0.30922330886796084
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00315534	0.30922330886796084
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00315534	0.30922330886796084
ALSTROM SYNDROME; ALMS	0.00315534	0.30922330886796084
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00315534	0.30922330886796084
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00315534	0.30922330886796084
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.00315534	0.30922330886796084
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00315534	0.30922330886796084
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00315534	0.30922330886796084
SHPRINTZEN OMPHALOCELE SYNDROME	0.00315534	0.30922330886796084
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00315534	0.30922330886796084
PYCNODYSOSTOSIS	0.00315534	0.30922330886796084
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00315534	0.30922330886796084
HURLER-SCHEIE SYNDROME	0.00315534	0.30922330886796084
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00315534	0.30922330886796084
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00315534	0.30922330886796084
TROCHLEA OF THE HUMERUS, APLASIA OF	0.00280112	0.27450975011764894
PARC SYNDROME	0.00280112	0.27450975011764894
VAN DER WOUDE SYNDROME	0.00280112	0.27450975011764894
#607361 MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3	0.00280112	0.27450975011764894
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.00280112	0.27450975011764894
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00280112	0.27450975011764894
ROSSELLI-GULIENETTI SYNDROME	0.00280112	0.27450975011764894
TREACHER COLLINS SYNDROME 2; TCS2	0.00280112	0.27450975011764894
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.00280112	0.27450975011764894
Temtamy preaxial brachydactyly syndrome	0.00280112	0.27450975011764894
STICKLER SYNDROME, TYPE III	0.00280112	0.27450975011764894
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00280112	0.27450975011764894
CDAGS SYNDROME	0.00280112	0.27450975011764894
%608572 BURN-MCKEOWN SYNDROME	0.00280112	0.27450975011764894
MECKEL SYNDROME, TYPE 10; MKS10	0.00280112	0.27450975011764894
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.00280112	0.27450975011764894
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.00280112	0.27450975011764894
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00280112	0.27450975011764894
CLEFT PALATE, X-LINKED	0.00280112	0.27450975011764894
PIERRE ROBIN SYNDROME AND OLIGODACTYLY	0.00280112	0.27450975011764894
STICKLER SYNDROME, TYPE II	0.00280112	0.27450975011764894
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00280112	0.27450975011764894
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00280112	0.27450975011764894
MECKEL SYNDROME, TYPE 5	0.00280112	0.27450975011764894
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00280112	0.27450975011764894
PALATOPHARYNGEAL INCOMPETENCE	0.00280112	0.27450975011764894
AGNATHIA-OTOCEPHALY COMPLEX	0.00280112	0.27450975011764894
TARP SYNDROME; TARPS	0.00280112	0.27450975011764894
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00280112	0.27450975011764894
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00280112	0.27450975011764894
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.00280112	0.27450975011764894
RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE	0.00280112	0.27450975011764894
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00280112	0.27450975011764894
CATEL-MANZKE SYNDROME; CATMANS	0.00280112	0.27450975011764894
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00280112	0.27450975011764894
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00280112	0.27450975011764894
HYDROLETHALUS SYNDROME 1	0.00280112	0.27450975011764894
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00280112	0.27450975011764894
DYSTONIA, JUVENILE-ONSET	0.00280112	0.27450975011764894
%119530 OROFACIAL CLEFT 1; OFC1;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1;;OROFACIAL CLEFT, NONSYNDROMIC; OFC;;CLEFT LIP/PALATE, NONSYNDROMIC	0.00280112	0.27450975011764894
MELNICK-NEEDLES SYNDROME	0.00280112	0.27450975011764894
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00280112	0.27450975011764894
ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE	0.00280112	0.27450975011764894
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	0.00280112	0.27450975011764894
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.00280112	0.27450975011764894
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.00280112	0.27450975011764894
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00280112	0.27450975011764894
BRANCHIOOTORENAL SYNDROME 1	0.00280112	0.27450975011764894
TREACHER COLLINS SYNDROME 3; TCS3	0.00280112	0.27450975011764894
#137215 GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, FAMILIAL DIFFUSEGASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFTPALATE, INCLUDED	0.00280112	0.27450975011764894
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00280112	0.27450975011764894
PIERRE ROBIN SYNDROME	0.00280112	0.27450975011764894
AASE-SMITH SYNDROME I	0.00280112	0.27450975011764894
THORACOABDOMINAL SYNDROME	0.00280112	0.27450975011764894
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.00280112	0.27450975011764894
HOLZGREVE SYNDROME	0.00280112	0.27450975011764894
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00280112	0.27450975011764894
GENITOPALATOCARDIAC SYNDROME	0.00280112	0.27450975011764894
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.00280112	0.27450975011764894
KNIEST-LIKE DYSPLASIA, LETHAL	0.00280112	0.27450975011764894
DIAPHANOSPONDYLODYSOSTOSIS	0.00280112	0.27450975011764894
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00280112	0.27450975011764894
FIBROCHONDROGENESIS 1; FBCG1	0.00280112	0.27450975011764894
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00280112	0.27450975011764894
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00280112	0.27450975011764894
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00280112	0.27450975011764894
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00280112	0.27450975011764894
Split hand/foot malformation 1 (SHFM1)	0.00280112	0.27450975011764894
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00280112	0.27450975011764894
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00280112	0.27450975011764894
BARTSOCAS-PAPAS SYNDROME; BPS	0.00280112	0.27450975011764894
KYPHOMELIC DYSPLASIA	0.00280112	0.27450975011764894
#608874 OROFACIAL CLEFT 5; OFC5;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 5	0.00280112	0.27450975011764894
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.00280112	0.27450975011764894
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.00280112	0.27450975011764894
SCHNECKENBECKEN DYSPLASIA	0.00280112	0.27450975011764894
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00280112	0.27450975011764894
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00280112	0.27450975011764894
RETINOBLASTOMA; RB1	0.00280112	0.27450975011764894
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.00280112	0.27450975011764894
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.00280112	0.27450975011764894
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00280112	0.27450975011764894
#612290 MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATEMICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, INCLUDED	0.00280112	0.27450975011764894
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00280112	0.27450975011764894
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00280112	0.27450975011764894
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00280112	0.27450975011764894
#606713 VAN DER WOUDE SYNDROME 2; VWS2	0.00280112	0.27450975011764894
#156550 KNIEST DYSPLASIA	0.00280112	0.27450975011764894
POPLITEAL PTERYGIUM SYNDROME	0.00280112	0.27450975011764894
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.00280112	0.27450975011764894
LYMPHEDEMA, HEREDITARY, II	0.00280112	0.27450975011764894
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.00280112	0.27450975011764894
OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	0.00280112	0.27450975011764894
ATELOSTEOGENESIS, TYPE I; AO1	0.00280112	0.27450975011764894
MECKEL SYNDROME, TYPE 6; MKS6	0.00280112	0.27450975011764894
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00280112	0.27450975011764894
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00280112	0.27450975011764894
#603543 LIMB-MAMMARY SYNDROME; LMS	0.00280112	0.27450975011764894
NATHALIE SYNDROME	0.0027933000000000003	0.27374339014523796
CANAVAN DISEASE	0.0027933000000000003	0.27374339014523796
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0027933000000000003	0.27374339014523796
#300914 DEAFNESS, X-LINKED 6; DFNX6	0.0027933000000000003	0.27374339014523796
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.0027933000000000003	0.27374339014523796
OPTICOCOCHLEODENTATE DEGENERATION	0.0027933000000000003	0.27374339014523796
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.0027933000000000003	0.27374339014523796
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0027933000000000003	0.27374339014523796
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0027933000000000003	0.27374339014523796
#614896 SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD	0.0027933000000000003	0.27374339014523796
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.0027933000000000003	0.27374339014523796
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.0027933000000000003	0.27374339014523796
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0027933000000000003	0.27374339014523796
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.0027933000000000003	0.27374339014523796
EAR EXOSTOSES	0.0027933000000000003	0.27374339014523796
USHER SYNDROME, TYPE ID	0.0027933000000000003	0.27374339014523796
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.0027933000000000003	0.27374339014523796
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0027933000000000003	0.27374339014523796
#158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;;FSHD2, DIGENIC;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B	0.0027933000000000003	0.27374339014523796
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.0027933000000000003	0.27374339014523796
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.0027933000000000003	0.27374339014523796
OTOSCLEROSIS 8; OTSC8	0.0027933000000000003	0.27374339014523796
#612645 DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.0027933000000000003	0.27374339014523796
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0027933000000000003	0.27374339014523796
PAGET DISEASE OF BONE 4; PDB4	0.0027933000000000003	0.27374339014523796
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.0027933000000000003	0.27374339014523796
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.0027933000000000003	0.27374339014523796
RETINAL VENOUS BEADING	0.0027933000000000003	0.27374339014523796
#610896 BRANCHIOOTORENAL SYNDROME 2; BOR2	0.0027933000000000003	0.27374339014523796
#614944 DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B	0.0027933000000000003	0.27374339014523796
SCLEROSTEOSIS 2; SOST2	0.0027933000000000003	0.27374339014523796
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.0027933000000000003	0.27374339014523796
ANUS, IMPERFORATE	0.0027933000000000003	0.27374339014523796
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.0027933000000000003	0.27374339014523796
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.0027933000000000003	0.27374339014523796
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.0027933000000000003	0.27374339014523796
KEUTEL SYNDROME; KTLS	0.0027933000000000003	0.27374339014523796
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.0027933000000000003	0.27374339014523796
GLYCOGEN STORAGE DISEASE II	0.0027933000000000003	0.27374339014523796
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.0027933000000000003	0.27374339014523796
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027933000000000003	0.27374339014523796
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.27374339014523796
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0027933000000000003	0.27374339014523796
184705 STEINFELD SYNDROME	0.0027933000000000003	0.27374339014523796
#613558 DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51;;CHROMOSOME 9Q21.11 DUPLICATION SYNDROME	0.0027933000000000003	0.27374339014523796
BRANCHIOOTIC SYNDROME 2	0.0027933000000000003	0.27374339014523796
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.0027933000000000003	0.27374339014523796
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0027933000000000003	0.27374339014523796
#614614 DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B	0.0027933000000000003	0.27374339014523796
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.0027933000000000003	0.27374339014523796
USHER SYNDROME, TYPE IID; USH2D	0.0027933000000000003	0.27374339014523796
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL DOMINANT 24	0.0027933000000000003	0.27374339014523796
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.0027933000000000003	0.27374339014523796
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.0027933000000000003	0.27374339014523796
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.0027933000000000003	0.27374339014523796
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.0027933000000000003	0.27374339014523796
ABCD SYNDROME	0.0027933000000000003	0.27374339014523796
PEROXISOME BIOGENESIS DISORDER 11B	0.0027933000000000003	0.27374339014523796
DEAFNESS, X-LINKED 7; DFNX7	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.0027933000000000003	0.27374339014523796
#613718 DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74	0.0027933000000000003	0.27374339014523796
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.0027933000000000003	0.27374339014523796
#600971 DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 6; NSRD6	0.0027933000000000003	0.27374339014523796
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.0027933000000000003	0.27374339014523796
OTOSCLEROSIS 3; OTSC3	0.0027933000000000003	0.27374339014523796
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.0027933000000000003	0.27374339014523796
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0027933000000000003	0.27374339014523796
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.0027933000000000003	0.27374339014523796
#602459 DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15	0.0027933000000000003	0.27374339014523796
DESANTO-SHINAWI SYNDROME	0.0027933000000000003	0.27374339014523796
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.0027933000000000003	0.27374339014523796
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.0027933000000000003	0.27374339014523796
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.0027933000000000003	0.27374339014523796
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0027933000000000003	0.27374339014523796
Adrenoleukodystrophy	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.0027933000000000003	0.27374339014523796
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.0027933000000000003	0.27374339014523796
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0027933000000000003	0.27374339014523796
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0027933000000000003	0.27374339014523796
TUNE DEAFNESS	0.0027933000000000003	0.27374339014523796
BRITTLE CORNEA SYNDROME 2; BCS2	0.0027933000000000003	0.27374339014523796
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.0027933000000000003	0.27374339014523796
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.0027933000000000003	0.27374339014523796
#614899 DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.0027933000000000003	0.27374339014523796
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.0027933000000000003	0.27374339014523796
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0027933000000000003	0.27374339014523796
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.0027933000000000003	0.27374339014523796
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.0027933000000000003	0.27374339014523796
KRABBE DISEASE	0.0027933000000000003	0.27374339014523796
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0027933000000000003	0.27374339014523796
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.0027933000000000003	0.27374339014523796
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.0027933000000000003	0.27374339014523796
PULMONIC STENOSIS AND DEAFNESS	0.0027933000000000003	0.27374339014523796
OSTEOGENESIS IMPERFECTA, TYPE I	0.0027933000000000003	0.27374339014523796
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.0027933000000000003	0.27374339014523796
#606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	0.0027933000000000003	0.27374339014523796
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.0027933000000000003	0.27374339014523796
DEMENTIA, FAMILIAL DANISH	0.0027933000000000003	0.27374339014523796
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0027933000000000003	0.27374339014523796
DEAFNESS, X-LINKED 5; DFNX5	0.0027933000000000003	0.27374339014523796
#615429 DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88	0.0027933000000000003	0.27374339014523796
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.0027933000000000003	0.27374339014523796
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0027933000000000003	0.27374339014523796
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.0027933000000000003	0.27374339014523796
AUROCEPHALOSYNDACTYLY	0.0027933000000000003	0.27374339014523796
DEAFNESS-CRANIOFACIAL SYNDROME	0.0027933000000000003	0.27374339014523796
PAGET DISEASE OF BONE 3; PDB3	0.0027933000000000003	0.27374339014523796
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0027933000000000003	0.27374339014523796
MENIERE DISEASE	0.0027933000000000003	0.27374339014523796
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.0027933000000000003	0.27374339014523796
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0027933000000000003	0.27374339014523796
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0027933000000000003	0.27374339014523796
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0027933000000000003	0.27374339014523796
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.0027933000000000003	0.27374339014523796
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.0027933000000000003	0.27374339014523796
#614934 DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70	0.0027933000000000003	0.27374339014523796
WILDERVANCK SYNDROME	0.0027933000000000003	0.27374339014523796
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.0027933000000000003	0.27374339014523796
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.0027933000000000003	0.27374339014523796
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.0027933000000000003	0.27374339014523796
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0027933000000000003	0.27374339014523796
#615629 DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56	0.0027933000000000003	0.27374339014523796
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.0027933000000000003	0.27374339014523796
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.0027933000000000003	0.27374339014523796
CLARK-BARAITSER SYNDROME	0.002786345	0.27306180016977516
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.002786345	0.27306180016977516
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.002786345	0.27306180016977516
METAPHYSEAL ACROSCYPHODYSPLASIA	0.002786345	0.27306180016977516
TENORIO SYNDROME; TNORS	0.002786345	0.27306180016977516
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.002786345	0.27306180016977516
LEBER OPTIC ATROPHY AND DYSTONIA	0.002786345	0.27306180016977516
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.002786345	0.27306180016977516
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.002786345	0.27306180016977516
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.002786345	0.27306180016977516
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.002786345	0.27306180016977516
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.002786345	0.27306180016977516
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.002786345	0.27306180016977516
VAN MALDERGEM SYNDROME 2; VMLDS2	0.002786345	0.27306180016977516
MYOCLONIC-ATONIC EPILEPSY	0.002786345	0.27306180016977516
Pontine tegmental cap dysplasia	0.002786345	0.27306180016977516
SOTOS SYNDROME 2	0.002786345	0.27306180016977516
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.002786345	0.27306180016977516
611961 STEVENSON-CAREY SYNDROME	0.002786345	0.27306180016977516
VAN MALDERGEM SYNDROME 1; VMLDS1	0.002786345	0.27306180016977516
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.002786345	0.27306180016977516
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.002786345	0.27306180016977516
LAMB-SHAFFER SYNDROME	0.002786345	0.27306180016977516
HYPERMANGANESEMIA WITH DYSTONIA 2	0.002786345	0.27306180016977516
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.002786345	0.27306180016977516
15q26 overgrowth syndrome	0.002786345	0.27306180016977516
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.002786345	0.27306180016977516
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.002786345	0.27306180016977516
IMMUNODEFICIENCY 23; IMD23	0.002786345	0.27306180016977516
MENTAL RETARDATION, X-LINKED 82	0.002786345	0.27306180016977516
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.002786345	0.27306180016977516
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.002786345	0.27306180016977516
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.002786345	0.27306180016977516
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.002786345	0.27306180016977516
DESBUQUOIS DYSPLASIA 1	0.002786345	0.27306180016977516
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.002786345	0.27306180016977516
FRONTOMETAPHYSEAL DYSPLASIA	0.002786345	0.27306180016977516
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.002786345	0.27306180016977516
JOUBERT SYNDROME 7	0.002786345	0.27306180016977516
GAPO SYNDROME; GAPOS	0.002786345	0.27306180016977516
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.002786345	0.27306180016977516
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.0024891	0.2439317912184555
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0024891	0.2439317912184555
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.0024891	0.2439317912184555
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0024891	0.2439317912184555
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.0024891	0.2439317912184555
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0024891	0.2439317912184555
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.0024891	0.2439317912184555
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0024891	0.2439317912184555
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.0024891	0.2439317912184555
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.0024891	0.2439317912184555
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.0024891	0.2439317912184555
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.0024891	0.2439317912184555
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0024891	0.2439317912184555
FORSYTHE-WAKELING SYNDROME; FWS	0.0024891	0.2439317912184555
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.0024891	0.2439317912184555
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0024891	0.2439317912184555
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0024891	0.2439317912184555
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.0024891	0.2439317912184555
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.0024891	0.2439317912184555
IMMUNODEFICIENCY 55; IMD55	0.0024891	0.2439317912184555
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0024891	0.2439317912184555
MEVALONIC ACIDURIA; MEVA	0.0024891	0.2439317912184555
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0024891	0.2439317912184555
MICROHYDRANENCEPHALY; MHAC	0.0024891	0.2439317912184555
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.0024891	0.2439317912184555
MICROPHTHALMIA, SYNDROMIC 3	0.0024891	0.2439317912184555
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.0024891	0.2439317912184555
DYSTONIA 28, CHILDHOOD-ONSET	0.0024891	0.2439317912184555
LISSENCEPHALY 4	0.0024891	0.2439317912184555
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0024891	0.2439317912184555
MARTSOLF SYNDROME	0.0024891	0.2439317912184555
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0024891	0.2439317912184555
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.0024891	0.2439317912184555
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.0024891	0.2439317912184555
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0024891	0.2439317912184555
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.0024891	0.2439317912184555
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0024891	0.2439317912184555
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.0024891	0.2439317912184555
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0024891	0.2439317912184555
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.0024891	0.2439317912184555
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.0024891	0.2439317912184555
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0024891	0.2439317912184555
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.0024891	0.2439317912184555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0024891	0.2439317912184555
ROIFMAN SYNDROME; RFMN	0.0024891	0.2439317912184555
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0024891	0.2439317912184555
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0024891	0.2439317912184555
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.0024891	0.2439317912184555
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.0024891	0.2439317912184555
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0024891	0.2439317912184555
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0024891	0.2439317912184555
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0024891	0.2439317912184555
KEARNS-SAYRE SYNDROME; KSS	0.0024891	0.2439317912184555
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0024891	0.2439317912184555
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0024891	0.2439317912184555
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0024891	0.2439317912184555
SECKEL SYNDROME 9; SCKL9	0.0024891	0.2439317912184555
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.0024891	0.2439317912184555
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.0024891	0.2439317912184555
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.0024891	0.2439317912184555
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.0024891	0.2439317912184555
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0024891	0.2439317912184555
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0024891	0.2439317912184555
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.0024891	0.2439317912184555
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0024891	0.2439317912184555
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.0024891	0.2439317912184555
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0024891	0.2439317912184555
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.0024891	0.2439317912184555
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0024891	0.2439317912184555
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0024891	0.2439317912184555
PERRAULT SYNDROME 3	0.0024891	0.2439317912184555
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.002120105	0.2077702825202698
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.002120105	0.2077702825202698
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.002120105	0.2077702825202698
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.002120105	0.2077702825202698
GOLDBERG-SHPRINTZEN SYNDROME	0.002120105	0.2077702825202698
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.002120105	0.2077702825202698
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.002120105	0.2077702825202698
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002120105	0.2077702825202698
MICROCEPHALY-CARDIOMYOPATHY	0.002120105	0.2077702825202698
Angelman syndrome (Type 1)	0.002120105	0.2077702825202698
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.002120105	0.2077702825202698
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.002120105	0.2077702825202698
MENTAL RETARDATION, X-LINKED 63	0.002120105	0.2077702825202698
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.002120105	0.2077702825202698
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002120105	0.2077702825202698
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.002120105	0.2077702825202698
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.002120105	0.2077702825202698
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.002120105	0.2077702825202698
GERODERMA OSTEODYSPLASTICUM; GO	0.002120105	0.2077702825202698
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.002120105	0.2077702825202698
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.002120105	0.2077702825202698
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.002120105	0.2077702825202698
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.002120105	0.2077702825202698
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.002120105	0.2077702825202698
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.002120105	0.2077702825202698
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.002120105	0.2077702825202698
Angelman syndrome (Type 2)	0.002120105	0.2077702825202698
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.002120105	0.2077702825202698
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002120105	0.2077702825202698
ENCEPHALOMALACIA, MULTILOCULAR	0.002120105	0.2077702825202698
TURNPENNY-FRY SYNDROME; TPFS	0.002120105	0.2077702825202698
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.002120105	0.2077702825202698
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.002120105	0.2077702825202698
LARYNGEAL ABDUCTOR PARALYSIS	0.002120105	0.2077702825202698
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.002120105	0.2077702825202698
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.002120105	0.2077702825202698
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.002120105	0.2077702825202698
FILIPPI SYNDROME; FLPIS	0.002120105	0.2077702825202698
JACOBSEN SYNDROME	0.002120105	0.2077702825202698
FACIOCARDIOMELIC SYNDROME	0.002120105	0.2077702825202698
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.002120105	0.2077702825202698
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.002120105	0.2077702825202698
2p15-16.1 microdeletion syndrome	0.002120105	0.2077702825202698
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.002120105	0.2077702825202698
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.002120105	0.2077702825202698
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.002120105	0.2077702825202698
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.002120105	0.2077702825202698
LATHOSTEROLOSIS	0.002120105	0.2077702825202698
MUCOLIPIDOSIS IV; ML4	0.002120105	0.2077702825202698
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.002120105	0.2077702825202698
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.002120105	0.2077702825202698
ACHALASIA-MICROCEPHALY SYNDROME	0.002120105	0.2077702825202698
ADENYLOSUCCINASE DEFICIENCY	0.002120105	0.2077702825202698
RING CHROMOSOME 14 SYNDROME	0.002120105	0.2077702825202698
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.002120105	0.2077702825202698
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.002120105	0.2077702825202698
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.002120105	0.2077702825202698
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.002120105	0.2077702825202698
COCKAYNE SYNDROME A; CSA	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.002120105	0.2077702825202698
DE SANCTIS-CACCHIONE SYNDROME	0.002120105	0.2077702825202698
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.002120105	0.2077702825202698
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.002120105	0.2077702825202698
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.002120105	0.2077702825202698
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.002120105	0.2077702825202698
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.002120105	0.2077702825202698
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.002120105	0.2077702825202698
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.002120105	0.2077702825202698
COFFIN-SIRIS SYNDROME 10; CSS10	0.002120105	0.2077702825202698
207790 ARACHNOID CYSTS, INTRACRANIAL	0.002120105	0.2077702825202698
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002120105	0.2077702825202698
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.002120105	0.2077702825202698
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.002120105	0.2077702825202698
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.002120105	0.2077702825202698
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.002120105	0.2077702825202698
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.002120105	0.2077702825202698
Cri du Chat Syndrome (5p deletion)	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002120105	0.2077702825202698
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.002120105	0.2077702825202698
Wolf-Hirschhorn Syndrome	0.002120105	0.2077702825202698
DUBOWITZ SYNDROME	0.002120105	0.2077702825202698
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.002120105	0.2077702825202698
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.002120105	0.2077702825202698
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.002120105	0.2077702825202698
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.002120105	0.2077702825202698
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002120105	0.2077702825202698
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.002120105	0.2077702825202698
MENTAL RETARDATION, X-LINKED 106; MRX106	0.002120105	0.2077702825202698
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.002120105	0.2077702825202698
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.002120105	0.2077702825202698
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.002120105	0.2077702825202698
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.002120105	0.2077702825202698
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002120105	0.2077702825202698
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.002120105	0.2077702825202698
TOWNES-BROCKS SYNDROME 1; TBS1	0.002120105	0.2077702825202698
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.002120105	0.2077702825202698
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.002120105	0.2077702825202698
PHENYLKETONURIA	0.002120105	0.2077702825202698
AICARDI-GOUTIERES SYNDROME 7	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.002120105	0.2077702825202698
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.002120105	0.2077702825202698
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.002120105	0.2077702825202698
#615328 SHAHEEN SYNDROME; SHNS	0.002120105	0.2077702825202698
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.002120105	0.2077702825202698
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.002120105	0.2077702825202698
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.002120105	0.2077702825202698
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.002120105	0.2077702825202698
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.002120105	0.2077702825202698
9q subtelomeric deletion syndrome	0.002120105	0.2077702825202698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.002120105	0.2077702825202698
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.002120105	0.2077702825202698
LISSENCEPHALY 8; LIS8	0.002120105	0.2077702825202698
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.002120105	0.2077702825202698
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.002120105	0.2077702825202698
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.002120105	0.2077702825202698
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.002120105	0.2077702825202698
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.002120105	0.2077702825202698
SUPRABULBAR PARESIS, CONGENITAL	0.002120105	0.2077702825202698
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.002120105	0.2077702825202698
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.002120105	0.2077702825202698
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.002120105	0.2077702825202698
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.002120105	0.2077702825202698
MENTAL RETARDATION, BUENOS AIRES TYPE	0.002120105	0.2077702825202698
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.002120105	0.2077702825202698
BARDET-BIEDL SYNDROME 20	0.002120105	0.2077702825202698
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.002058185	0.20170212273872357
WIEDEMANN-STEINER SYNDROME; WDSTS	0.002058185	0.20170212273872357
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.002058185	0.20170212273872357
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.002058185	0.20170212273872357
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.002058185	0.20170212273872357
BIEMOND SYNDROME II	0.002058185	0.20170212273872357
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.002058185	0.20170212273872357
MENTAL RETARDATION, X-LINKED 92	0.002058185	0.20170212273872357
Rothmund-Thomson syndrome	0.002058185	0.20170212273872357
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.002058185	0.20170212273872357
SONODA SYNDROME	0.002058185	0.20170212273872357
FOUNTAIN SYNDROME	0.002058185	0.20170212273872357
GLYCEROL KINASE DEFICIENCY; GKD	0.002058185	0.20170212273872357
MENTAL RETARDATION, X-LINKED 2	0.002058185	0.20170212273872357
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.002058185	0.20170212273872357
NIEMANN-PICK DISEASE, TYPE A	0.002058185	0.20170212273872357
CROME SYNDROME	0.002058185	0.20170212273872357
COFFIN-SIRIS SYNDROME 2; CSS2	0.002058185	0.20170212273872357
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.002058185	0.20170212273872357
XQ25 DUPLICATION SYNDROME	0.002058185	0.20170212273872357
Helsmoortel-van der Aa syndrome	0.002058185	0.20170212273872357
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.002058185	0.20170212273872357
CHROMOSOME 2q37 DELETION SYNDROME	0.002058185	0.20170212273872357
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.002058185	0.20170212273872357
COSTELLO SYNDROME; CSTLO	0.002058185	0.20170212273872357
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.002058185	0.20170212273872357
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.002058185	0.20170212273872357
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.002058185	0.20170212273872357
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.002058185	0.20170212273872357
NOONAN SYNDROME 5; NS5	0.002058185	0.20170212273872357
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002058185	0.20170212273872357
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.002058185	0.20170212273872357
MEND SYNDROME; MEND	0.002058185	0.20170212273872357
245800 LAURENCE-MOON SYNDROME	0.002058185	0.20170212273872357
LESCH-NYHAN SYNDROME; LNS	0.002058185	0.20170212273872357
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.002058185	0.20170212273872357
RODRIGUES BLINDNESS	0.002058185	0.20170212273872357
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.002058185	0.20170212273872357
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.002058185	0.20170212273872357
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.002058185	0.20170212273872357
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.002058185	0.20170212273872357
SJOGREN-LARSSON SYNDROME; SLS	0.002058185	0.20170212273872357
22q11.2 distal deletion syndrome	0.002058185	0.20170212273872357
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.002058185	0.20170212273872357
NOONAN SYNDROME 8; NS8	0.002058185	0.20170212273872357
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.002058185	0.20170212273872357
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.002058185	0.20170212273872357
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.002058185	0.20170212273872357
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.002058185	0.20170212273872357
THUMB DEFORMITY AND ALOPECIA	0.002058185	0.20170212273872357
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.002058185	0.20170212273872357
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.002058185	0.20170212273872357
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.002058185	0.20170212273872357
LUSCAN-LUMISH SYNDROME; LLS	0.002058185	0.20170212273872357
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.002058185	0.20170212273872357
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.002058185	0.20170212273872357
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.002058185	0.20170212273872357
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.002058185	0.20170212273872357
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.002058185	0.20170212273872357
MENTAL RETARDATION, X-LINKED 99	0.002058185	0.20170212273872357
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.002058185	0.20170212273872357
WILLIAMS-BEUREN SYNDROME; WBS	0.002058185	0.20170212273872357
KENNERKNECHT SYNDROME	0.002058185	0.20170212273872357
Williams-Beuren Syndrome (WBS)	0.002058185	0.20170212273872357
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.002058185	0.20170212273872357
MENTAL RETARDATION, X-LINKED 45	0.002058185	0.20170212273872357
SPINOCEREBELLAR ATAXIA 47; SCA47	0.002058185	0.20170212273872357
SACCHAROPINURIA	0.002058185	0.20170212273872357
Cat-Eye Syndrome (Type I)	0.002058185	0.20170212273872357
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.002058185	0.20170212273872357
CHROMOSOME 18P DELETION SYNDROME	0.002058185	0.20170212273872357
GURRIERI SYNDROME	0.002058185	0.20170212273872357
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.002058185	0.20170212273872357
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.002058185	0.20170212273872357
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.002058185	0.20170212273872357
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.002058185	0.20170212273872357
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.002058185	0.20170212273872357
Smith-Magenis Syndrome	0.002058185	0.20170212273872357
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.002058185	0.20170212273872357
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.002058185	0.20170212273872357
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.002058185	0.20170212273872357
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.002058185	0.20170212273872357
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.002058185	0.20170212273872357
NEURAMINIDASE DEFICIENCY	0.002058185	0.20170212273872357
MENTAL RETARDATION, X-LINKED 84	0.002058185	0.20170212273872357
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.002058185	0.20170212273872357
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00194175	0.19029149314950622
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00194175	0.19029149314950622
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00194175	0.19029149314950622
MARFANOID HABITUS WITH SITUS INVERSUS	0.00194175	0.19029149314950622
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00194175	0.19029149314950622
#609340 SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28	0.00194175	0.19029149314950622
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00194175	0.19029149314950622
SPRENGEL DEFORMITY	0.00194175	0.19029149314950622
Ullrich congenital muscular dystrophy 1	0.00194175	0.19029149314950622
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00194175	0.19029149314950622
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00194175	0.19029149314950622
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00194175	0.19029149314950622
CARTILAGE-HAIR HYPOPLASIA; CHH	0.00194175	0.19029149314950622
MYOPATHY, DISTAL, 1; MPD1	0.00194175	0.19029149314950622
TOWNES-BROCKS SYNDROME 2; TBS2	0.00194175	0.19029149314950622
TIBIAL TORSION, BILATERAL MEDIAL	0.00194175	0.19029149314950622
#608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA	0.00194175	0.19029149314950622
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00194175	0.19029149314950622
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00194175	0.19029149314950622
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.00194175	0.19029149314950622
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.00194175	0.19029149314950622
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00194175	0.19029149314950622
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.00194175	0.19029149314950622
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.00194175	0.19029149314950622
#255160 MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB;;MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	0.00194175	0.19029149314950622
NEMALINE MYOPATHY 1; NEM1	0.00194175	0.19029149314950622
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.00194175	0.19029149314950622
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.00194175	0.19029149314950622
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00194175	0.19029149314950622
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00194175	0.19029149314950622
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00194175	0.19029149314950622
SPONDYLOCAMPTODACTYLY	0.00194175	0.19029149314950622
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00194175	0.19029149314950622
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00194175	0.19029149314950622
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00194175	0.19029149314950622
SYRINGOMYELIA, ISOLATED	0.00194175	0.19029149314950622
LERI-WEILL DYSCHONDROSTEOSIS	0.00194175	0.19029149314950622
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00194175	0.19029149314950622
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.00194175	0.19029149314950622
PSEUDOACHONDROPLASIA	0.00194175	0.19029149314950622
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00194175	0.19029149314950622
SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1	0.00194175	0.19029149314950622
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00194175	0.19029149314950622
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.00194175	0.19029149314950622
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00194175	0.19029149314950622
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.00194175	0.19029149314950622
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.00194175	0.19029149314950622
#614895 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	0.00194175	0.19029149314950622
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00194175	0.19029149314950622
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00194175	0.19029149314950622
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.00194175	0.19029149314950622
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00194175	0.19029149314950622
SALIH MYOPATHY; SALMY	0.00194175	0.19029149314950622
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00194175	0.19029149314950622
PSEUDODIASTROPHIC DYSPLASIA	0.00194175	0.19029149314950622
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00194175	0.19029149314950622
ANGELMAN SYNDROME	0.00194175	0.19029149314950622
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00194175	0.19029149314950622
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00194175	0.19029149314950622
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.00194175	0.19029149314950622
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00194175	0.19029149314950622
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.00194175	0.19029149314950622
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00194175	0.19029149314950622
POSTERIOR COLUMN ATAXIA	0.00194175	0.19029149314950622
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00194175	0.19029149314950622
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00194175	0.19029149314950622
FRAGILE X MENTAL RETARDATION SYNDROME	0.00194175	0.19029149314950622
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00194175	0.19029149314950622
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.00194175	0.19029149314950622
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00194175	0.19029149314950622
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.00194175	0.19029149314950622
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.00194175	0.19029149314950622
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00194175	0.19029149314950622
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.00194175	0.19029149314950622
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.00194175	0.19029149314950622
ODONTOCHONDRODYSPLASIA; ODCD	0.00194175	0.19029149314950622
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00194175	0.19029149314950622
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00194175	0.19029149314950622
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.00194175	0.19029149314950622
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00194175	0.19029149314950622
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00194175	0.19029149314950622
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00194175	0.19029149314950622
METATROPIC DYSPLASIA	0.00194175	0.19029149314950622
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00194175	0.19029149314950622
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00194175	0.19029149314950622
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00194175	0.19029149314950622
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.00194175	0.19029149314950622
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00194175	0.19029149314950622
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00194175	0.19029149314950622
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.00194175	0.19029149314950622
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00194175	0.19029149314950622
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00194175	0.19029149314950622
RAYNAUD-CLAES SYNDROME; MRXSRC	0.00194175	0.19029149314950622
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00194175	0.19029149314950622
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.00194175	0.19029149314950622
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00194175	0.19029149314950622
PETTIGREW SYNDROME	0.00194175	0.19029149314950622
#608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY	0.00194175	0.19029149314950622
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.00194175	0.19029149314950622
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00194175	0.19029149314950622
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00194175	0.19029149314950622
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.00194175	0.19029149314950622
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.00194175	0.19029149314950622
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00194175	0.19029149314950622
#614434 CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2	0.00194175	0.19029149314950622
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.00194175	0.19029149314950622
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.00194175	0.19029149314950622
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00194175	0.19029149314950622
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.00194175	0.19029149314950622
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.00194175	0.19029149314950622
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.00194175	0.19029149314950622
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00194175	0.19029149314950622
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.00194175	0.19029149314950622
RETT SYNDROME, CONGENITAL VARIANT	0.00194175	0.19029149314950622
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.00194175	0.19029149314950622
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00194175	0.19029149314950622
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00194175	0.19029149314950622
OPSISMODYSPLASIA; OPSMD	0.00194175	0.19029149314950622
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00194175	0.19029149314950622
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00194175	0.19029149314950622
#253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C;;MUSCULAR DYSTROPHY, DUCHENNE-LIKE;;DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;;DMDA;;ADHALIN DEFICIENCY, SECONDARY;;SARCOGLYCAN, GAMMA, DEFICIENCY OF;;SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICANTYPE; SCARMD;;MAGHREBIAN MYOPATHY	0.00194175	0.19029149314950622
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00194175	0.19029149314950622
#168400 PARASTREMMATIC DWARFISM	0.00194175	0.19029149314950622
CZECH DYSPLASIA, METATARSAL TYPE	0.00194175	0.19029149314950622
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00194175	0.19029149314950622
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00194175	0.19029149314950622
COFFIN-SIRIS SYNDROME 8; CSS8	0.00194175	0.19029149314950622
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00194175	0.19029149314950622
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.00194175	0.19029149314950622
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.00194175	0.19029149314950622
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.00194175	0.19029149314950622
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.00194175	0.19029149314950622
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.00194175	0.19029149314950622
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.00194175	0.19029149314950622
231970 GLUTEAL MUSCLES, ABSENCE OF	0.00194175	0.19029149314950622
HEMIHYPERPLASIA, ISOLATED	0.00194175	0.19029149314950622
MYOPATHY, SCAPULOHUMEROPERONEAL	0.00194175	0.19029149314950622
DUANE-RADIAL RAY SYNDROME; DRRS	0.00194175	0.19029149314950622
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.00194175	0.19029149314950622
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.00194175	0.19029149314950622
BAKER-GORDON SYNDROME; BAGOS	0.00194175	0.19029149314950622
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.00194175	0.19029149314950622
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00194175	0.19029149314950622
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00194175	0.19029149314950622
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.00194175	0.19029149314950622
Osteogenesis imperfecta, type IX	0.00194175	0.19029149314950622
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.00194175	0.19029149314950622
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.00194175	0.19029149314950622
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00194175	0.19029149314950622
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00194175	0.19029149314950622
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00194175	0.19029149314950622
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00194175	0.19029149314950622
PYLE DISEASE; PYL	0.00194175	0.19029149314950622
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00194175	0.19029149314950622
THORACOLARYNGOPELVIC DYSPLASIA	0.00194175	0.19029149314950622
SPONDYLOCOSTAL DYSOSTOSIS 5	0.00194175	0.19029149314950622
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00194175	0.19029149314950622
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00194175	0.19029149314950622
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.00194175	0.19029149314950622
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00194175	0.19029149314950622
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00194175	0.19029149314950622
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00194175	0.19029149314950622
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.00194175	0.19029149314950622
#307150 HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2;;CHROMOSOME Xq27.1 INTERCHROMOSOMAL INSERTION SYNDROME;;CGH;;HCG	0.00194175	0.19029149314950622
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.00194175	0.19029149314950622
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.00194175	0.19029149314950622
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00127551	0.12499997550000089
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.12499997550000089
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.00127551	0.12499997550000089
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.00127551	0.12499997550000089
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00127551	0.12499997550000089
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.00127551	0.12499997550000089
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.00127551	0.12499997550000089
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00127551	0.12499997550000089
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.00127551	0.12499997550000089
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.00127551	0.12499997550000089
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00127551	0.12499997550000089
RHIZOMELIC SYNDROME	0.00127551	0.12499997550000089
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.00127551	0.12499997550000089
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00127551	0.12499997550000089
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.00127551	0.12499997550000089
CHROMOSOME 19p13.13 DELETION SYNDROME	0.00127551	0.12499997550000089
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00127551	0.12499997550000089
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.00127551	0.12499997550000089
MEIER-GORLIN SYNDROME 8; MGORS8	0.00127551	0.12499997550000089
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00127551	0.12499997550000089
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00127551	0.12499997550000089
AL-RAQAD SYNDROME; ARS	0.00127551	0.12499997550000089
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.00127551	0.12499997550000089
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00127551	0.12499997550000089
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.00127551	0.12499997550000089
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00127551	0.12499997550000089
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.00127551	0.12499997550000089
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00127551	0.12499997550000089
LISSENCEPHALY 3; LIS3	0.00127551	0.12499997550000089
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.00127551	0.12499997550000089
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.00127551	0.12499997550000089
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.00127551	0.12499997550000089
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00127551	0.12499997550000089
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.00127551	0.12499997550000089
Miller-Dieker syndrome (MDS)	0.00127551	0.12499997550000089
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00127551	0.12499997550000089
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.00127551	0.12499997550000089
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00127551	0.12499997550000089
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.00127551	0.12499997550000089
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00127551	0.12499997550000089
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00127551	0.12499997550000089
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.00127551	0.12499997550000089
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00127551	0.12499997550000089
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00127551	0.12499997550000089
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.00127551	0.12499997550000089
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.00127551	0.12499997550000089
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.00127551	0.12499997550000089
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.00127551	0.12499997550000089
MEIER-GORLIN SYNDROME 5; MGORS5	0.00127551	0.12499997550000089
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00127551	0.12499997550000089
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.00127551	0.12499997550000089
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.00127551	0.12499997550000089
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.00127551	0.12499997550000089
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00127551	0.12499997550000089
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00127551	0.12499997550000089
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.12499997550000089
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00127551	0.12499997550000089
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00127551	0.12499997550000089
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.00127551	0.12499997550000089
FUMARASE DEFICIENCY; FMRD	0.00127551	0.12499997550000089
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.00127551	0.12499997550000089
INFANTILE LIVER FAILURE SYNDROME 1	0.00127551	0.12499997550000089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00127551	0.12499997550000089
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00127551	0.12499997550000089
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00127551	0.12499997550000089
Xq28 (MECP2) duplication	0.00127551	0.12499997550000089
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.00127551	0.12499997550000089
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00127551	0.12499997550000089
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.00127551	0.12499997550000089
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00127551	0.12499997550000089
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00127551	0.12499997550000089
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.00127551	0.12499997550000089
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.00127551	0.12499997550000089
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00127551	0.12499997550000089
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00127551	0.12499997550000089
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00127551	0.12499997550000089
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00127551	0.12499997550000089
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00127551	0.12499997550000089
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00127551	0.12499997550000089
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00127551	0.12499997550000089
Leukotriene C4 synthase deficiency	0.00127551	0.12499997550000089
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00127551	0.12499997550000089
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00127551	0.12499997550000089
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00127551	0.12499997550000089
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00127551	0.12499997550000089
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.00127551	0.12499997550000089
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.00127551	0.12499997550000089
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00127551	0.12499997550000089
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00127551	0.12499997550000089
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.00127551	0.12499997550000089
BOWEN-CONRADI SYNDROME	0.00127551	0.12499997550000089
MACDERMOT-WINTER SYNDROME	0.00127551	0.12499997550000089
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.00127551	0.12499997550000089
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.00127551	0.12499997550000089
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00127551	0.12499997550000089
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00127551	0.12499997550000089
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00127551	0.12499997550000089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00127551	0.12499997550000089
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00127551	0.12499997550000089
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00127551	0.12499997550000089
CARDIAC LIPIDOSIS, FAMILIAL	0.00127551	0.12499997550000089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00127551	0.12499997550000089
PSEUDO-TORCH SYNDROME 2	0.00127551	0.12499997550000089
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.00127551	0.12499997550000089
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00127551	0.12499997550000089
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00127551	0.12499997550000089
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00127551	0.12499997550000089
MECKEL SYNDROME 12; MKS12	0.00127551	0.12499997550000089
MEIER-GORLIN SYNDROME 3; MGORS3	0.00127551	0.12499997550000089
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00127551	0.12499997550000089
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.00127551	0.12499997550000089
MEIER-GORLIN SYNDROME 2; MGORS2	0.00127551	0.12499997550000089
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.00127551	0.12499997550000089
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.00127551	0.12499997550000089
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00127551	0.12499997550000089
601453 TRICHODENTAL DYSPLASIA	0.00127551	0.12499997550000089
LISSENCEPHALY 2; LIS2	0.00127551	0.12499997550000089
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00127551	0.12499997550000089
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00127551	0.12499997550000089
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00127551	0.12499997550000089
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.00127551	0.12499997550000089
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00127551	0.12499997550000089
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00127551	0.12499997550000089
ADAMS-OLIVER SYNDROME 3; AOS3	0.00127551	0.12499997550000089
AICARDI-GOUTIERES SYNDROME 6	0.00127551	0.12499997550000089
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00127551	0.12499997550000089
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00127551	0.12499997550000089
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.00127551	0.12499997550000089
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00127551	0.12499997550000089
PAINE SYNDROME	0.00127551	0.12499997550000089
LIG4 SYNDROME	0.00127551	0.12499997550000089
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00127551	0.12499997550000089
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00127551	0.12499997550000089
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00127551	0.12499997550000089
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00127551	0.12499997550000089
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.00127551	0.12499997550000089
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00127551	0.12499997550000089
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00127551	0.12499997550000089
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00127551	0.12499997550000089
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00127551	0.12499997550000089
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00127551	0.12499997550000089
SECKEL SYNDROME 7; SCKL7	0.00127551	0.12499997550000089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00127551	0.12499997550000089
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.00127551	0.12499997550000089
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.00127551	0.12499997550000089
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.00127551	0.12499997550000089
ADAMS-OLIVER SYNDROME 2; AOS2	0.00127551	0.12499997550000089
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00127551	0.12499997550000089
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.00127551	0.12499997550000089
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00127551	0.12499997550000089
AICARDI-GOUTIERES SYNDROME 5	0.00127551	0.12499997550000089
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00127551	0.12499997550000089
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00127551	0.12499997550000089
HYPERREFLEXIA	0.00127551	0.12499997550000089
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00127551	0.12499997550000089
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.00127551	0.12499997550000089
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.00127551	0.12499997550000089
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00127551	0.12499997550000089
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00127551	0.12499997550000089
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.00127551	0.12499997550000089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00127551	0.12499997550000089
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00127551	0.12499997550000089
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00127551	0.12499997550000089
SECKEL SYNDROME 10; SCKL10	0.00127551	0.12499997550000089
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00127551	0.12499997550000089
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00127551	0.12499997550000089
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00127551	0.12499997550000089
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00127551	0.12499997550000089
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00127551	0.12499997550000089
Glycosylphosphatidylinositol biosynthesis defect 18	0.00127551	0.12499997550000089
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00127551	0.12499997550000089
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00127551	0.12499997550000089
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00127551	0.12499997550000089
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.00127551	0.12499997550000089
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.00127551	0.12499997550000089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.00127551	0.12499997550000089
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.00127551	0.12499997550000089
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00127551	0.12499997550000089
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00127551	0.12499997550000089
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00127551	0.12499997550000089
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00127551	0.12499997550000089
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.00121359	0.11893181571845464
THREE M SYNDROME 2; 3M2	0.00121359	0.11893181571845464
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00121359	0.11893181571845464
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00121359	0.11893181571845464
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00121359	0.11893181571845464
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00121359	0.11893181571845464
#186570 TARSAL-CARPAL COALITION SYNDROME; TCC; SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED	0.00121359	0.11893181571845464
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00121359	0.11893181571845464
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00121359	0.11893181571845464
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00121359	0.11893181571845464
Trichothiodystrophy 5, nonphotosensitive	0.00121359	0.11893181571845464
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.00121359	0.11893181571845464
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00121359	0.11893181571845464
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00121359	0.11893181571845464
WERNER SYNDROME; WRN	0.00121359	0.11893181571845464
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.00121359	0.11893181571845464
#612650 CILIARY DYSKINESIA, PRIMARY, 12; CILD12	0.00121359	0.11893181571845464
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00121359	0.11893181571845464
SEPTOOPTIC DYSPLASIA	0.00121359	0.11893181571845464
NOONAN SYNDROME 10; NS10	0.00121359	0.11893181571845464
HYPOPHOSPHATEMIC BONE DISEASE	0.00121359	0.11893181571845464
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00121359	0.11893181571845464
NIEMANN-PICK DISEASE, TYPE B	0.00121359	0.11893181571845464
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.00121359	0.11893181571845464
GLYCOGEN STORAGE DISEASE IB	0.00121359	0.11893181571845464
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00121359	0.11893181571845464
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00121359	0.11893181571845464
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00121359	0.11893181571845464
608028 THAI SYMPHALANGISM SYNDROME	0.00121359	0.11893181571845464
GLYCOGEN STORAGE DISEASE IA	0.00121359	0.11893181571845464
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.00121359	0.11893181571845464
GLYCOGEN STORAGE DISEASE IXB	0.00121359	0.11893181571845464
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.00121359	0.11893181571845464
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00121359	0.11893181571845464
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00121359	0.11893181571845464
HAIRY ELBOWS	0.00121359	0.11893181571845464
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00121359	0.11893181571845464
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00121359	0.11893181571845464
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00121359	0.11893181571845464
CRANIOECTODERMAL DYSPLASIA 4	0.00121359	0.11893181571845464
FRIAS SYNDROME	0.00121359	0.11893181571845464
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00121359	0.11893181571845464
PROPIONIC ACIDEMIA	0.00121359	0.11893181571845464
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.00121359	0.11893181571845464
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00121359	0.11893181571845464
OSTEOGENESIS IMPERFECTA, TYPE V	0.00121359	0.11893181571845464
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00121359	0.11893181571845464
PRECOCIOUS PUBERTY, CENTRAL	0.00121359	0.11893181571845464
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00121359	0.11893181571845464
#612781 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B;;IGHD IB;;DWARFISM OF SINDH	0.00121359	0.11893181571845464
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.00121359	0.11893181571845464
DIAMOND-BLACKFAN ANEMIA 4	0.00121359	0.11893181571845464
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00121359	0.11893181571845464
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00121359	0.11893181571845464
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.00121359	0.11893181571845464
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00121359	0.11893181571845464
OVARIAN DYSGENESIS 4; ODG4	0.00121359	0.11893181571845464
PELVIS-SHOULDER DYSPLASIA	0.00121359	0.11893181571845464
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.00121359	0.11893181571845464
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00121359	0.11893181571845464
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00121359	0.11893181571845464
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00121359	0.11893181571845464
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00121359	0.11893181571845464
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00121359	0.11893181571845464
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00121359	0.11893181571845464
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.00121359	0.11893181571845464
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00121359	0.11893181571845464
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00121359	0.11893181571845464
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00121359	0.11893181571845464
Potocki-Lupski syndrome (17p11.2 duplication syndrome)	0.00121359	0.11893181571845464
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.00121359	0.11893181571845464
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00121359	0.11893181571845464
CHITAYAT SYNDROME	0.00121359	0.11893181571845464
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00121359	0.11893181571845464
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00121359	0.11893181571845464
DIAMOND-BLACKFAN ANEMIA 5	0.00121359	0.11893181571845464
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00121359	0.11893181571845464
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00121359	0.11893181571845464
RUIJS-AALFS SYNDROME; RJALS	0.00121359	0.11893181571845464
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00121359	0.11893181571845464
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00121359	0.11893181571845464
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00121359	0.11893181571845464
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.00121359	0.11893181571845464
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00121359	0.11893181571845464
STORMORKEN SYNDROME; STRMK	0.00121359	0.11893181571845464
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00121359	0.11893181571845464
PALLISTER-HALL SYNDROME	0.00121359	0.11893181571845464
AROMATASE EXCESS SYNDROME	0.00121359	0.11893181571845464
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00121359	0.11893181571845464
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00121359	0.11893181571845464
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00121359	0.11893181571845464
EXOSTOSES, MULTIPLE, TYPE I	0.00121359	0.11893181571845464
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00121359	0.11893181571845464
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.00121359	0.11893181571845464
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00121359	0.11893181571845464
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00121359	0.11893181571845464
ANAUXETIC DYSPLASIA 2; ANXD2	0.00121359	0.11893181571845464
NASODIGITOACOUSTIC SYNDROME	0.00121359	0.11893181571845464
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.00121359	0.11893181571845464
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00121359	0.11893181571845464
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.00121359	0.11893181571845464
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00121359	0.11893181571845464
BRUCK SYNDROME 2	0.00121359	0.11893181571845464
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.00121359	0.11893181571845464
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.00121359	0.11893181571845464
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00121359	0.11893181571845464
#226670 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY;;EBS-MD;;EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY;;MD-EBS; MDEBS	0.00121359	0.11893181571845464
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00121359	0.11893181571845464
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00121359	0.11893181571845464
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.00121359	0.11893181571845464
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00121359	0.11893181571845464
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00121359	0.11893181571845464
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00121359	0.11893181571845464
DENT DISEASE 1	0.00121359	0.11893181571845464
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00121359	0.11893181571845464
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00121359	0.11893181571845464
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00121359	0.11893181571845464
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00121359	0.11893181571845464
#615072 BRACHYDACTYLY, TYPE A1, C; BDA1C	0.00121359	0.11893181571845464
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00121359	0.11893181571845464
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00121359	0.11893181571845464
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00121359	0.11893181571845464
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00121359	0.11893181571845464
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.00121359	0.11893181571845464
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00121359	0.11893181571845464
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.00121359	0.11893181571845464
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00121359	0.11893181571845464
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00121359	0.11893181571845464
WEILL-MARCHESANI SYNDROME 3	0.00121359	0.11893181571845464
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00121359	0.11893181571845464
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00121359	0.11893181571845464
LEGG-CALVE-PERTHES DISEASE	0.00121359	0.11893181571845464
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00121359	0.11893181571845464
EHLERS-DANLOS SYNDROME, TYPE I	0.00121359	0.11893181571845464
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00121359	0.11893181571845464
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00121359	0.11893181571845464
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00121359	0.11893181571845464
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00121359	0.11893181571845464
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.00121359	0.11893181571845464
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00121359	0.11893181571845464
HARTNUP DISORDER	0.00121359	0.11893181571845464
WIDOW&#39;S PEAK SYNDROME	0.00121359	0.11893181571845464
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00121359	0.11893181571845464
SCHIZOPHRENIA 1; SCZD1	0.00121359	0.11893181571845464
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00121359	0.11893181571845464
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00121359	0.11893181571845464
NOONAN SYNDROME 9; NS9	0.00121359	0.11893181571845464
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.00121359	0.11893181571845464
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00121359	0.11893181571845464
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00121359	0.11893181571845464
SPONDYLOPERIPHERAL DYSPLASIA	0.00121359	0.11893181571845464
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	0.00121359	0.11893181571845464
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00121359	0.11893181571845464
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00121359	0.11893181571845464
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.00121359	0.11893181571845464
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00121359	0.11893181571845464
BRACHYDACTYLY, TYPE A6	0.00121359	0.11893181571845464
TRICHOHEPATOENTERIC SYNDROME 1	0.00121359	0.11893181571845464
#307800 HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR;;HYPOPHOSPHATEMIA, X-LINKED; XLH;;HYP;;VITAMIN D-RESISTANT RICKETS, X-LINKED;;HYPOPHOSPHATEMIC VITAMIN D-RESISTANT RICKETS; HPDR	0.00121359	0.11893181571845464
NOONAN SYNDROME 2; NS2	0.00121359	0.11893181571845464
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00121359	0.11893181571845464
#276880 UROCANASE DEFICIENCY	0.00121359	0.11893181571845464
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00121359	0.11893181571845464
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00121359	0.11893181571845464
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00121359	0.11893181571845464
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00121359	0.11893181571845464
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00121359	0.11893181571845464
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00121359	0.11893181571845464
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00121359	0.11893181571845464
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00121359	0.11893181571845464
STIFF SKIN SYNDROME	0.00121359	0.11893181571845464
#300555 DENT DISEASE 2	0.00121359	0.11893181571845464
RHYNS SYNDROME; RHYNS	0.00121359	0.11893181571845464
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00121359	0.11893181571845464
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00121359	0.11893181571845464
SATOYOSHI SYNDROME	0.00121359	0.11893181571845464
#300582 SHORT STATURE, IDIOPATHIC, X-LINKED; ISS	0.00121359	0.11893181571845464
DIAMOND-BLACKFAN ANEMIA 8	0.00121359	0.11893181571845464
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00121359	0.11893181571845464
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00121359	0.11893181571845464
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00121359	0.11893181571845464
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00121359	0.11893181571845464
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00121359	0.11893181571845464
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00121359	0.11893181571845464
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00121359	0.11893181571845464
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00121359	0.11893181571845464
PFEIFFER-PALM-TELLER SYNDROME	0.00121359	0.11893181571845464
THORACOPELVIC DYSOSTOSIS	0.00121359	0.11893181571845464
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.00121359	0.11893181571845464
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00121359	0.11893181571845464
IMMUNODEFICIENCY 58; IMD58	0.00121359	0.11893181571845464
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00121359	0.11893181571845464
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00121359	0.11893181571845464
AURICULOOSTEODYSPLASIA	0.00121359	0.11893181571845464
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00121359	0.11893181571845464
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00121359	0.11893181571845464
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00121359	0.11893181571845464
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00121359	0.11893181571845464
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00121359	0.11893181571845464
#613986 PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6	0.00121359	0.11893181571845464
EXOSTOSES, MULTIPLE, TYPE II	0.00121359	0.11893181571845464
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00121359	0.11893181571845464
PYGMY	0.00121359	0.11893181571845464
BRACHYDACTYLY, TYPE E2; BDE2	0.00121359	0.11893181571845464
CRANIOECTODERMAL DYSPLASIA 3	0.00121359	0.11893181571845464
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00121359	0.11893181571845464
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00121359	0.11893181571845464
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00121359	0.11893181571845464
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00121359	0.11893181571845464
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00121359	0.11893181571845464
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.00121359	0.11893181571845464
CASPASE 8 DEFICIENCY	0.00121359	0.11893181571845464
#604864 OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	0.00121359	0.11893181571845464
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00121359	0.11893181571845464
600736 VELOFACIOSKELETAL SYNDROME	0.00121359	0.11893181571845464
SPINAL DYSPLASIA, ANHALT TYPE	0.00121359	0.11893181571845464
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00121359	0.11893181571845464
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00121359	0.11893181571845464
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00121359	0.11893181571845464
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00121359	0.11893181571845464
NOONAN SYNDROME 3; NS3	0.00121359	0.11893181571845464
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00121359	0.11893181571845464
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00121359	0.11893181571845464
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00121359	0.11893181571845464
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.00121359	0.11893181571845464
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.00121359	0.11893181571845464
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00121359	0.11893181571845464
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00121359	0.11893181571845464
STICKLER SYNDROME, TYPE V; STL5	0.00121359	0.11893181571845464
SAUL-WILSON SYNDROME; SWILS	0.00121359	0.11893181571845464
OVARIAN DYSGENESIS 5; ODG5	0.00121359	0.11893181571845464
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00121359	0.11893181571845464
GRACILE BONE DYSPLASIA; GCLEB	0.00121359	0.11893181571845464
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00121359	0.11893181571845464
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00121359	0.11893181571845464
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00121359	0.11893181571845464
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00121359	0.11893181571845464
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00121359	0.11893181571845464
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00121359	0.11893181571845464
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.00121359	0.11893181571845464
HYPOPHOSPHATASIA, CHILDHOOD	0.00121359	0.11893181571845464
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00121359	0.11893181571845464
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.00121359	0.11893181571845464
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00121359	0.11893181571845464
NOONAN SYNDROME 11; NS11	0.00121359	0.11893181571845464
RADIAL-RENAL SYNDROME	0.00121359	0.11893181571845464
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.00121359	0.11893181571845464
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00121359	0.11893181571845464
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00121359	0.11893181571845464
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00121359	0.11893181571845464
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00121359	0.11893181571845464
#612649 CILIARY DYSKINESIA, PRIMARY, 11; CILD11	0.00121359	0.11893181571845464
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00121359	0.11893181571845464
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00121359	0.11893181571845464
CORNEODERMATOOSSEOUS SYNDROME	0.00121359	0.11893181571845464
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00121359	0.11893181571845464
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00121359	0.11893181571845464
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00121359	0.11893181571845464
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	0.00121359	0.11893181571845464
#615139 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS	0.00121359	0.11893181571845464
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00121359	0.11893181571845464
IMMUNODEFICIENCY 36; IMD36	0.00121359	0.11893181571845464
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00121359	0.11893181571845464
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00121359	0.11893181571845464
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00121359	0.11893181571845464
EIKEN SYNDROME	0.00121359	0.11893181571845464
NAVAJO NEUROHEPATOPATHY	0.00121359	0.11893181571845464
ARTERIAL TORTUOSITY SYNDROME	0.000844595	0.08277030702026893
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000844595	0.08277030702026893
WAISMAN SYNDROME; WSMN	0.000844595	0.08277030702026893
PEROXISOME BIOGENESIS DISORDER 3B	0.000844595	0.08277030702026893
HYPOCHONDROPLASIA	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000844595	0.08277030702026893
GRANGE SYNDROME; GRNG	0.000844595	0.08277030702026893
2q37 monosomy	0.000844595	0.08277030702026893
%614329 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	0.000844595	0.08277030702026893
BARDET-BIEDL SYNDROME 13; BBS13	0.000844595	0.08277030702026893
Prader-Willi Syndrome (Type 2)	0.000844595	0.08277030702026893
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000844595	0.08277030702026893
MORQUIO SYNDROME C	0.000844595	0.08277030702026893
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.000844595	0.08277030702026893
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000844595	0.08277030702026893
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000844595	0.08277030702026893
JOUBERT SYNDROME 6	0.000844595	0.08277030702026893
AGENESIS OF CEREBRAL WHITE MATTER	0.000844595	0.08277030702026893
BARDET-BIEDL SYNDROME 8; BBS8	0.000844595	0.08277030702026893
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.000844595	0.08277030702026893
BARDET-BIEDL SYNDROME 4; BBS4	0.000844595	0.08277030702026893
CEPHALIN LIPIDOSIS	0.000844595	0.08277030702026893
15q13.3 microdeletion syndrome	0.000844595	0.08277030702026893
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000844595	0.08277030702026893
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	0.000844595	0.08277030702026893
ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	0.000844595	0.08277030702026893
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000844595	0.08277030702026893
HYDROXYPROLINEMIA	0.000844595	0.08277030702026893
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000844595	0.08277030702026893
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000844595	0.08277030702026893
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.000844595	0.08277030702026893
MICROCEPHALY - INTELLECTUAL DISABILITY - PHALANGEAL AND NEUROLOGICAL ANOMALIES	0.000844595	0.08277030702026893
DICARBOXYLICAMINO ACIDURIA	0.000844595	0.08277030702026893
HYPERLEUCINE-ISOLEUCINEMIA	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 19	0.000844595	0.08277030702026893
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000844595	0.08277030702026893
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	0.000844595	0.08277030702026893
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.000844595	0.08277030702026893
ALPORT SYNDROME - INTELLECTUAL DISABILITY - MIDFACE HYPOPLASIA - ELLIPTOCYTOSIS	0.000844595	0.08277030702026893
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.000844595	0.08277030702026893
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000844595	0.08277030702026893
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000844595	0.08277030702026893
FRONTONASAL DYSPLASIA 1; FND1	0.000844595	0.08277030702026893
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.000844595	0.08277030702026893
CARNOSINEMIA	0.000844595	0.08277030702026893
GALACTOSE EPIMERASE DEFICIENCY	0.000844595	0.08277030702026893
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.000844595	0.08277030702026893
BARDET-BIEDL SYNDROME 7; BBS7	0.000844595	0.08277030702026893
MENTAL RETARDATION, FRA12A TYPE	0.000844595	0.08277030702026893
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000844595	0.08277030702026893
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.000844595	0.08277030702026893
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000844595	0.08277030702026893
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	0.000844595	0.08277030702026893
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.000844595	0.08277030702026893
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000844595	0.08277030702026893
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000844595	0.08277030702026893
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.000844595	0.08277030702026893
ELLIS-VAN CREVELD SYNDROME	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 77	0.000844595	0.08277030702026893
CHANARIN-DORFMAN SYNDROME	0.000844595	0.08277030702026893
EPILEPSY-TELANGIECTASIA	0.000844595	0.08277030702026893
224250 DYSMYELINATION WITH JAUNDICE	0.000844595	0.08277030702026893
1q21.1 recurrent microduplication (possible susceptibility locus for neurodevelopmental disorders)	0.000844595	0.08277030702026893
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000844595	0.08277030702026893
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.000844595	0.08277030702026893
HISTIDINEMIA	0.000844595	0.08277030702026893
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.000844595	0.08277030702026893
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.000844595	0.08277030702026893
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.000844595	0.08277030702026893
BEHR SYNDROME	0.000844595	0.08277030702026893
HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	0.000844595	0.08277030702026893
METACHROMATIC LEUKODYSTROPHY	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000844595	0.08277030702026893
#262000 BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD	0.000844595	0.08277030702026893
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.000844595	0.08277030702026893
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000844595	0.08277030702026893
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000844595	0.08277030702026893
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000844595	0.08277030702026893
#613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	0.000844595	0.08277030702026893
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.000844595	0.08277030702026893
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000844595	0.08277030702026893
ARGININOSUCCINIC ACIDURIA	0.000844595	0.08277030702026893
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.000844595	0.08277030702026893
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000844595	0.08277030702026893
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000844595	0.08277030702026893
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.000844595	0.08277030702026893
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.000844595	0.08277030702026893
MAPLE SYRUP URINE DISEASE; MSUD	0.000844595	0.08277030702026893
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000844595	0.08277030702026893
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000844595	0.08277030702026893
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.000844595	0.08277030702026893
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000844595	0.08277030702026893
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000844595	0.08277030702026893
HOOFT DISEASE	0.000844595	0.08277030702026893
CUTIS VERTICIS GYRATA AND MENTAL DEFICIENCY	0.000844595	0.08277030702026893
OROFACIODIGITAL SYNDROME III	0.000844595	0.08277030702026893
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.000844595	0.08277030702026893
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.000844595	0.08277030702026893
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000844595	0.08277030702026893
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.000844595	0.08277030702026893
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.000844595	0.08277030702026893
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000844595	0.08277030702026893
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000844595	0.08277030702026893
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000844595	0.08277030702026893
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000844595	0.08277030702026893
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.000844595	0.08277030702026893
CYSTEINE PEPTIDURIA	0.000844595	0.08277030702026893
CHROMOSOME 16p13.2 DELETION SYNDROME	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000844595	0.08277030702026893
601095 HARROD SYNDROME	0.000844595	0.08277030702026893
JOUBERT SYNDROME 1	0.000844595	0.08277030702026893
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000844595	0.08277030702026893
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000844595	0.08277030702026893
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000844595	0.08277030702026893
DYSAUTONOMIA-LIKE DISORDER	0.000844595	0.08277030702026893
LEBER CONGENITAL AMAUROSIS, TYPE I	0.000844595	0.08277030702026893
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.000844595	0.08277030702026893
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.000844595	0.08277030702026893
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.000844595	0.08277030702026893
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000844595	0.08277030702026893
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.000844595	0.08277030702026893
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.000844595	0.08277030702026893
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.000844595	0.08277030702026893
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000844595	0.08277030702026893
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000844595	0.08277030702026893
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000844595	0.08277030702026893
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.000844595	0.08277030702026893
CAHMR SYNDROME	0.000844595	0.08277030702026893
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.000844595	0.08277030702026893
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.000844595	0.08277030702026893
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000844595	0.08277030702026893
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.000844595	0.08277030702026893
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000844595	0.08277030702026893
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000844595	0.08277030702026893
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000844595	0.08277030702026893
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000844595	0.08277030702026893
#613612 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I;;CDG IIi; CDGIIi	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.000844595	0.08277030702026893
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.000844595	0.08277030702026893
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000844595	0.08277030702026893
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.000844595	0.08277030702026893
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.000844595	0.08277030702026893
BARDET-BIEDL SYNDROME 3; BBS3	0.000844595	0.08277030702026893
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 81	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000844595	0.08277030702026893
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000844595	0.08277030702026893
ELSAHY-WATERS SYNDROME; ESWS	0.000844595	0.08277030702026893
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000844595	0.08277030702026893
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000844595	0.08277030702026893
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 97; MRX97	0.000844595	0.08277030702026893
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000844595	0.08277030702026893
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000844595	0.08277030702026893
SALLA DISEASE	0.000844595	0.08277030702026893
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000844595	0.08277030702026893
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000844595	0.08277030702026893
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.000844595	0.08277030702026893
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000844595	0.08277030702026893
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000844595	0.08277030702026893
TIMOTHY SYNDROME; TS	0.000844595	0.08277030702026893
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.000844595	0.08277030702026893
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.000844595	0.08277030702026893
OCULORENOCEREBELLAR SYNDROME	0.000844595	0.08277030702026893
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000844595	0.08277030702026893
T-SUBSTANCE ANOMALY	0.000844595	0.08277030702026893
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000844595	0.08277030702026893
PELGER-HUET ANOMALY; PHA	0.000844595	0.08277030702026893
IMMUNODEFICIENCY 47	0.000844595	0.08277030702026893
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.000844595	0.08277030702026893
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000844595	0.08277030702026893
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000844595	0.08277030702026893
DERMATOLEUKODYSTROPHY	0.000844595	0.08277030702026893
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.000844595	0.08277030702026893
#614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	0.000844595	0.08277030702026893
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.000844595	0.08277030702026893
BARDET-BIEDL SYNDROME 14; BBS14	0.000844595	0.08277030702026893
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.000844595	0.08277030702026893
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000844595	0.08277030702026893
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.000844595	0.08277030702026893
GALACTOSEMIA	0.000844595	0.08277030702026893
LEBER CONGENITAL AMAUROSIS, TYPE II	0.000844595	0.08277030702026893
17q21.31 recurrent microdeletion syndrome	0.000844595	0.08277030702026893
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000844595	0.08277030702026893
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000844595	0.08277030702026893
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000844595	0.08277030702026893
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000844595	0.08277030702026893
HYPERCALCEMIA, INFANTILE, 1	0.000844595	0.08277030702026893
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.000844595	0.08277030702026893
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000844595	0.08277030702026893
ALPHA-METHYLACETOACETIC ACIDURIA	0.000844595	0.08277030702026893
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000844595	0.08277030702026893
GLUTATHIONURIA	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000844595	0.08277030702026893
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000844595	0.08277030702026893
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000844595	0.08277030702026893
ATR-16 syndrome	0.000844595	0.08277030702026893
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.000844595	0.08277030702026893
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.000844595	0.08277030702026893
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000844595	0.08277030702026893
KETOADIPICACIDURIA	0.000844595	0.08277030702026893
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.000844595	0.08277030702026893
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000844595	0.08277030702026893
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000844595	0.08277030702026893
PENDRED SYNDROME	0.000844595	0.08277030702026893
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.000844595	0.08277030702026893
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.000844595	0.08277030702026893
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.000844595	0.08277030702026893
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.000844595	0.08277030702026893
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.000844595	0.08277030702026893
MACROCEPHALY/AUTISM SYNDROME	0.000844595	0.08277030702026893
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000844595	0.08277030702026893
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.000844595	0.08277030702026893
IMINOGLYCINURIA	0.000844595	0.08277030702026893
#300706 MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST;;MENTAL RETARDATION AND MACROCEPHALY SYNDROME	0.000844595	0.08277030702026893
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.000844595	0.08277030702026893
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 1	0.000844595	0.08277030702026893
JOUBERT SYNDROME 28	0.000844595	0.08277030702026893
LISSENCEPHALY 1; LIS1	0.000844595	0.08277030702026893
KEIPERT SYNDROME; KPTS	0.000844595	0.08277030702026893
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000844595	0.08277030702026893
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.000844595	0.08277030702026893
#611093 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 22; MRT22	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000844595	0.08277030702026893
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000844595	0.08277030702026893
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.000844595	0.08277030702026893
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000844595	0.08277030702026893
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000844595	0.08277030702026893
EDINBURGH MALFORMATION SYNDROME	0.000844595	0.08277030702026893
FORMIMINOTRANSFERASE DEFICIENCY	0.000844595	0.08277030702026893
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000844595	0.08277030702026893
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.000844595	0.08277030702026893
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000844595	0.08277030702026893
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000844595	0.08277030702026893
HYPERPROLINEMIA, TYPE II	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 72	0.000844595	0.08277030702026893
#614249 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18	0.000844595	0.08277030702026893
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.000844595	0.08277030702026893
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000844595	0.08277030702026893
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.000844595	0.08277030702026893
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000844595	0.08277030702026893
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.000844595	0.08277030702026893
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000844595	0.08277030702026893
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000844595	0.08277030702026893
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.000844595	0.08277030702026893
WOODHOUSE-SAKATI SYNDROME	0.000844595	0.08277030702026893
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD	0.000844595	0.08277030702026893
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000844595	0.08277030702026893
OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000844595	0.08277030702026893
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000844595	0.08277030702026893
RAHMAN SYNDROME	0.000844595	0.08277030702026893
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.000844595	0.08277030702026893
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000844595	0.08277030702026893
MECKEL SYNDROME 13; MKS13	0.000844595	0.08277030702026893
Oliver-McFarlane syndrome	0.000844595	0.08277030702026893
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.000844595	0.08277030702026893
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000844595	0.08277030702026893
NEPHRONOPHTHISIS 18; NPHP18	0.000844595	0.08277030702026893
JOUBERT SYNDROME 15	0.000844595	0.08277030702026893
JOUBERT SYNDROME 3; JBTS3	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000844595	0.08277030702026893
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.000844595	0.08277030702026893
ICHTHYOSIS AND MALE HYPOGONADISM	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000844595	0.08277030702026893
Potocki-Shaffer syndrome	0.000844595	0.08277030702026893
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.000844595	0.08277030702026893
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.000844595	0.08277030702026893
JOUBERT SYNDROME 2	0.000844595	0.08277030702026893
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000844595	0.08277030702026893
SOTOS SYNDROME 3	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	0.000844595	0.08277030702026893
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000844595	0.08277030702026893
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000844595	0.08277030702026893
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.000844595	0.08277030702026893
8p23.1 deletion syndrome	0.000844595	0.08277030702026893
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.000844595	0.08277030702026893
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.000844595	0.08277030702026893
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.000844595	0.08277030702026893
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.000844595	0.08277030702026893
CARDIAC-UROGENITAL SYNDROME; CUGS	0.000844595	0.08277030702026893
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.000844595	0.08277030702026893
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000844595	0.08277030702026893
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.000844595	0.08277030702026893
#300705 MENTAL RETARDATION, X-LINKED 17; MRX17;;MENTAL RETARDATION, X-LINKED 31; MRX31	0.000844595	0.08277030702026893
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000844595	0.08277030702026893
OPTIC ATROPHY 2	0.000844595	0.08277030702026893
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.000844595	0.08277030702026893
PAPILLORENAL SYNDROME	0.000844595	0.08277030702026893
OSTEOPENIA AND SPARSE HAIR	0.000844595	0.08277030702026893
JOUBERT SYNDROME 27	0.000844595	0.08277030702026893
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.000844595	0.08277030702026893
CHROMOSOME 5Q12 DELETION SYNDROME	0.000844595	0.08277030702026893
WAGR 11p13 deletion syndrome	0.000844595	0.08277030702026893
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000844595	0.08277030702026893
HOMOCARNOSINOSIS	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000844595	0.08277030702026893
CITRULLINEMIA, CLASSIC	0.000844595	0.08277030702026893
BARDET-BIEDL SYNDROME 6; BBS6	0.000844595	0.08277030702026893
#614815 JOUBERT SYNDROME 18; JBTS18	0.000844595	0.08277030702026893
Sotos syndrome	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000844595	0.08277030702026893
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000844595	0.08277030702026893
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000844595	0.08277030702026893
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000844595	0.08277030702026893
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000844595	0.08277030702026893
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000844595	0.08277030702026893
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.000844595	0.08277030702026893
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.000844595	0.08277030702026893
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.000844595	0.08277030702026893
LAMBERT SYNDROME	0.000844595	0.08277030702026893
1p36 microdeletion syndrome	0.000844595	0.08277030702026893
JOUBERT SYNDROME 30; JBTS30	0.000844595	0.08277030702026893
OLIVER SYNDROME	0.000844595	0.08277030702026893
CHYLOMICRON RETENTION DISEASE	0.000844595	0.08277030702026893
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000844595	0.08277030702026893
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.000844595	0.08277030702026893
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.000844595	0.08277030702026893
12q14 microdeletion syndrome	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000844595	0.08277030702026893
7q11.23 duplication syndrome	0.000844595	0.08277030702026893
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.000844595	0.08277030702026893
HYPERPROLINEMIA, TYPE I	0.000844595	0.08277030702026893
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.000844595	0.08277030702026893
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 100	0.000844595	0.08277030702026893
LANDAU-KLEFFNER SYNDROME	0.000844595	0.08277030702026893
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000844595	0.08277030702026893
BARDET-BIEDL SYNDROME 9; BBS9	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	0.000844595	0.08277030702026893
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000844595	0.08277030702026893
Cerebral creatine deficiency syndrome 3	0.000844595	0.08277030702026893
JOUBERT SYNDROME 8	0.000844595	0.08277030702026893
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.000844595	0.08277030702026893
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000844595	0.08277030702026893
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000844595	0.08277030702026893
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000844595	0.08277030702026893
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000844595	0.08277030702026893
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000844595	0.08277030702026893
PSEUDOURIDINURIA AND MENTAL DEFECT	0.000844595	0.08277030702026893
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.000844595	0.08277030702026893
BARDET-BIEDL SYNDROME 19; BBS19	0.000844595	0.08277030702026893
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.000844595	0.08277030702026893
NIEMANN-PICK DISEASE, TYPE C2	0.000844595	0.08277030702026893
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000844595	0.08277030702026893
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000844595	0.08277030702026893
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000844595	0.08277030702026893
TRYPTOPHANURIA WITH DWARFISM	0.000844595	0.08277030702026893
GRISCELLI SYNDROME, TYPE 1	0.000844595	0.08277030702026893
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 23	0.000844595	0.08277030702026893
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.000844595	0.08277030702026893
LYSINE MALABSORPTION SYNDROME	0.000844595	0.08277030702026893
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.000844595	0.08277030702026893
#612900 CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000844595	0.08277030702026893
POTOCKI-SHAFFER SYNDROME	0.000844595	0.08277030702026893
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.000844595	0.08277030702026893
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000844595	0.08277030702026893
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000844595	0.08277030702026893
JOUBERT SYNDROME 21	0.000844595	0.08277030702026893
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.000844595	0.08277030702026893
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000844595	0.08277030702026893
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.000844595	0.08277030702026893
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.000844595	0.08277030702026893
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.000844595	0.08277030702026893
DIBASIC AMINO ACIDURIA I	0.000844595	0.08277030702026893
#615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 4	0.000844595	0.08277030702026893
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.000844595	0.08277030702026893
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000844595	0.08277030702026893
Cerebral creatine deficiency syndrome 2	0.000844595	0.08277030702026893
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000844595	0.08277030702026893
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000844595	0.08277030702026893
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 95	0.000844595	0.08277030702026893
JOUBERT SYNDROME 10	0.000844595	0.08277030702026893
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.000844595	0.08277030702026893
MEGALENCEPHALY	0.000844595	0.08277030702026893
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.000844595	0.08277030702026893
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000844595	0.08277030702026893
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000844595	0.08277030702026893
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000844595	0.08277030702026893
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000844595	0.08277030702026893
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.000844595	0.08277030702026893
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.000844595	0.08277030702026893
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.000844595	0.08277030702026893
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.000844595	0.08277030702026893
SPASTIC PARAPLEGIA 16, X-LINKED	0.000844595	0.08277030702026893
FOLATE MALABSORPTION, HEREDITARY	0.000844595	0.08277030702026893
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000844595	0.08277030702026893
CREE MENTAL RETARDATION SYNDROME	0.000844595	0.08277030702026893
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.000844595	0.08277030702026893
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000844595	0.08277030702026893
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.000844595	0.08277030702026893
TELECANTHUS	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 103	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000844595	0.08277030702026893
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000844595	0.08277030702026893
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000844595	0.08277030702026893
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.000844595	0.08277030702026893
AUTISM, SUSCEPTIBILITY TO, 18	0.000844595	0.08277030702026893
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.000844595	0.08277030702026893
#611090 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12	0.000844595	0.08277030702026893
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 53	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 41	0.000844595	0.08277030702026893
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.000844595	0.08277030702026893
GLYCINE ENCEPHALOPATHY; GCE	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000844595	0.08277030702026893
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000844595	0.08277030702026893
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 88	0.000844595	0.08277030702026893
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.000844595	0.08277030702026893
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.000844595	0.08277030702026893
JOUBERT SYNDROME 5	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 105; MRX105	0.000844595	0.08277030702026893
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000844595	0.08277030702026893
LEIGH SYNDROME; LS	0.000844595	0.08277030702026893
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 46	0.000844595	0.08277030702026893
KIFAFA SEIZURE DISORDER	0.000844595	0.08277030702026893
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.000844595	0.08277030702026893
3q29 microdeletion syndrome	0.000844595	0.08277030702026893
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000844595	0.08277030702026893
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000844595	0.08277030702026893
Bardet-Biedl syndrome 2	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000844595	0.08277030702026893
MENTAL RETARDATION, X-LINKED 20	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000844595	0.08277030702026893
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000844595	0.08277030702026893
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.000844595	0.08277030702026893
ELEJALDE DISEASE	0.000844595	0.08277030702026893
CHROMOSOME 13q14 DELETION SYNDROME	0.000844595	0.08277030702026893
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.000844595	0.08277030702026893
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000844595	0.08277030702026893
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.000844595	0.08277030702026893
8p23.1 duplication syndrome	0.000844595	0.08277030702026893
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000844595	0.08277030702026893
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000844595	0.08277030702026893
GILLESPIE SYNDROME; GLSP	0.000844595	0.08277030702026893
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.000844595	0.08277030702026893
HYDROXYLYSINURIA	0.000844595	0.08277030702026893
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.000844595	0.08277030702026893
16p11.2-p12.2 microdeletion syndrome	0.000844595	0.08277030702026893
22q11 duplication syndrome	0.000844595	0.08277030702026893
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.000844595	0.08277030702026893
AUTISM	0.000844595	0.08277030702026893
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.000844595	0.08277030702026893
PYRUVATE CARBOXYLASE DEFICIENCY	0.000844595	0.08277030702026893
CROUZON SYNDROME	0.000844595	0.08277030702026893
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000844595	0.08277030702026893
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.000844595	0.08277030702026893
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000844595	0.08277030702026893
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000844595	0.08277030702026893
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.000844595	0.08277030702026893
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000844595	0.08277030702026893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000844595	0.08277030702026893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000844595	0.08277030702026893
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.000844595	0.08277030702026893
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.000844595	0.08277030702026893
HYPERLYSINEMIA, TYPE I	0.000844595	0.08277030702026893
STURGE-WEBER SYNDROME	0.000844595	0.08277030702026893
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.000844595	0.08277030702026893
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000844595	0.08277030702026893
Prader-Willi syndrome (Type 1)	0.000844595	0.08277030702026893
SPASTIC DIPLEGIA, INFANTILE TYPE	0.000844595	0.08277030702026893
